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ABSTRACT
COMPLEXATION OF POLYELECTROLYTES
MAY 2008
JOANNA G. POOL, B.S. UNIVERSITY OF PUGET SOUND, TACOMA, WA
M.S. UNIVERSITY OF MASSACHUSETTS AMHERST, MA
Ph.D. UNIVERSITY OF MASSACHUSETTS AMHERST, MA
Directed by: Professor Murugappan Muthukumar
Complexation found in nature was the inspiration and motivation to study three
model systems to gain understanding into the underlying parameters that govern these
events. Static and dynamic light scattering was predominately used to understand the
complexation in three model systems: complexation of antimicrobial polymers with
biomimetic vesicles, the complexation of protein to a semi-flexible polyelectrolyte and
with a flexible polyelectrolyte.
Characterization of antimicrobial polymers in solution and their interactions
with biomimetic vesicles were investigated in order to understand how antimicrobial
polymers interacted with and killed bacteria. These studies observed that an aggregation
of the vesicles correlated with antimicrobial activity. For these synthetic polymer
systems, aggregation appeared to be a necessary component for antimicrobial activity,
but was not indicative of activity.
Inspired by complexation found in nature between DNA and RNA and proteins
model polyelectrolyte-protein systems were also investigated. The focus of this section
was to understand how polymer flexibility, concentration, protein concentration, and
v
ionic strength affected the phase behavior and presence of soluble aggregates in
solution. Construction of phase diagrams for both semi-flexible and flexible
polyelectrolye systems dsDNA and hyaluronic acid showed different phase diagrams,
yet amazingly both systems showed a spontaneous selection of size of ~230nm away
from any phase boundary and was irrespective of salt concentration, polymer
concentration, persistence length or protein concentration.
It was possible to gain insight into the internal packing of these two
polyelectrolyte-protein complexes through static hght scattering and fractal dimension
analysis. Comparisons of the fractal dimension analysis of the DNA-lysozyme and HA-
lysozyme was not affected by salt concentration and from analysis of the fractal
dimension it was observed DNA-lysozyme aggregates, had a denser aggregate structure
than the HA-lysozyme aggregate. It was also observed that away from the phase
boundaries in each system the aggregate sizes and fractal dimensions were irrespective
of polymer, salt, persistence length or protein concentration.
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CHAPTER 1
INTRODUCTION
1.1 Introduction
Complexation in nature drives a multitude of biological processes that are
imperative to life and order in the world around us. The human cell is filled with an
amazing array of molecular machinery that functions through the self assembly and
complexation of different molecules, from small salts to large pieces of DNA and
proteins. The manner in which biological molecules complex with each other is critical
to understanding how host defense peptides kill bacteria, the self assembly of hnRNP
complexes, and the complexation of histones with double stranded DNA (dsDNA) to
form chromosomes. This research aims to investigate model systems that would give
further understanding into the fundamentals that govern the underlying mechanisms of
these complexation events found in nature.
1.2 Complexation of Antimicrobial Polyelectrolytes and Bacteria
Antimicrobial polypeptides, also known as host defense peptides, are ubiquitous
in the natural world. They are diverse in their modes of action and in their structures.
The nature of antimicrobial activity in host defense peptides has been of interest over
1
many decades. " How these natural polyelectrolytes complex with and kill bacteria has
been subject to a number of debates that question the structure-function relationship of
these host defense peptides" secondary structures.' "'"^ Many researchers have concluded
that it is the incorporation of hydrophobic and cationic groups that make these peptides
antimicrobial.' '' The fundamental structural principles underlying all classes of
1
antimicrobials is the ability of these molecules to adopt a shape in which clusters of
hydrophobic and cationic amino acids are spatially organized in discrete sectors of the
molecule to create an amphipathic design.^ Studies have shown that for many of these
natural polymers there is great specificity in the amino acid sequence, and minor
changes to this sequence greatly impact the resulting polypeptide's secondary structure
and most importantly its antimicrobial behavior.'
"'
It has been hypothesized that the basic amphiphilic nature is important for the
large class of peptides that include melittin, magainins and ceropins in order to kill
target cells. These investigations into host defense peptides bring up an important
question: How do antimicrobial peptides kill microbes? In studies with magainins, a
decrease in membrane potential has been observed upon addition of the peptides. The
decrease in membrane potentials is most likely attributed to the formation of ion
channels;^ protegrins are also believed to form pores. ^ Thus far, a few models of how
these host defense peptides kill bacteria have been proposed.
Antimicrobial activity of host defense peptides is believed to occur through the
disruption of the integrity of the membrane bilayer structure. There are a couple of
different types of proposed mechanisms of how these peptides kill bacteria. Some
peptides are believed to have a 'carpet mechanism' whereby peptides accumulate on
the bilayer surface and disrupt it in a detergent-like manner."" Another proposed
mechanism is the 'barrel-stave' model where peptides aggregate on the surface of the
bacteria and insert into the membrane bilayer creating a pore. The third proposed model
is the 'toroidal model' where peptides on the surface aggregate and induce the bilayer of
2
the membrane to bend and become incorporated into the pore that is formed with the
peptide."
The various mechanisms of how natural antimicrobials kill bacteria are
important to understand, yet these studies elicit further questions about what actually
governs the antimicrobial nature of these biopolymers. The factors that cause these
polypeptides to have antimicrobial activity have captured the attention of many
researchers who desire to create new, effective types of antimicrobials. It has been
observed that the presence of cationic and hydrophobic regions in these antimicrobials
is important indicators of their activity. Many host defense peptides segregate their
cationic and hydrophobic groups in such a manner that their global structure is of an
amphiphilic design. It is beheved that the presence of these cationic and hydrophobic
groups are what causes membrane permeabilization, which gives these peptides the
ability to kill bacteria.' Taking this design parameter of cationic and hydrophobic
regions, synthetic peptides and polymers have been designed to utilize these
characteristics which has resulted in the design of antimicrobial molecules." ''^
Host defense peptides have great specificity in amino acid sequences in order to
maintain their antimicrobial activity, yet efforts to create synthetic antimicrobial
molecules have demonstrated that it is only necessary to incorporate cationic and
hydrophobic groups in order to obtain antimicrobial molecules." ''^ '^ ''^ Utilization of a
cationic-hydrophobic design is an important component in achieving antimicrobial
activity.'" '*^ Developing synthetic antimicrobials is more cost and time effective than
the current methods of peptide synthesis.
Synthetic antimicrobial systems have been made in the Tew and Coughlin
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research groups at the University of Massachusetts, Amherst. These polymers utihzed
the design of incorporating hydrophobic and cationic groups into synthetic
polymers.''^ While there are many studies into the mechanism of how host defense
peptides kill bacteria, how synthetic systems kill bacteria has not yet been elucidated. In
this study we characterized a series of synthetic antimicrobial polymers in solution. We
wanted to determine the underlying mechanisms of how these polymers killed bacteria;
hence, we investigated how these polymers interacted with biomimetic vesicles through
physical characterization techniques.
1.3 Complexation of Proteins with Polyelectrolytes
1.3.1 Complexation of Proteins with a Semi-flexible Polyelectrolyte, dsDNA
Double-stranded DNA (dsDNA) is a semi-flexible polyelectrolyte that has a
persistence length, Ip, of approximately 50 nm.'' In eukaryotic cells, dsDNA
complexes with octameric proteins called histones and self assemble into chromosomes
(Figure 1.1). If dsDNA were unwound from its chromosomal form it would measure
centimeters in length, yet this semi-flexible polyelectrolyte self assembles with histones
and compacts itself into micron-sized chromosomes inside the nucleus."'* It is in the
nucleus that RNA can be transcribed as well as more DNA synthesized from this
compacted dsDNA.
1.3.2 Complexation of Proteins to a Flexible Polyelectrolyte, mRNA
Another area of polyelectrolyte complexation that is of importance in nature is
the adsorption of proteins to messenger RNA, mRNA. Messenger RNA is a flexible
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polyelectrolyte that has a small average persistence length, , of about 2 nm."" Within
the nucleus, mRNA is transcribed from dsDNA and translocated into the cytoplasm,
where it is then translated into proteins. In a eukaryotic cell, the nucleus contains a
cell's genetic material and is enclosed in a phospholipid bilayer that is filled with many
protein pores called Nuclear Pore Complexes, NPCs. These protein pores are quite
large, approximately 125 million Daltons (Da) in size, and contain 50-100 different
proteins (Figure 1.2). In its closed state the NFC allows ions, small metabolites and
globular proteins up to 9 nm in diameter to diffuse between the cytosol and the nucleus,
although equilibrium of these species and the cytosol is not necessarily established.
Looking at the varied functions of mRNA shuttling proteins into and out of the nucleus
and acting as a template for translation of proteins, it becomes apparent that mRNA is
versatile and more mobile than dsDNA, as dsDNA is retained within the nucleus. These
two fascinating polyelectrolyte-protein systems found in nature inspired and motivated
this study of the complexation of proteins to polyelectrolytes.
1.3.3 Adsorption of a Polyelectrolyte onto a Charged Curved Surface
1.3.3.1 Theory of Polyelectrolyte Adsorption onto Curved Surfaces
One theory that is of particular interest to these two cases of polyelectrolyte
complexation with proteins is the analytical calculations done by von Goeler and
Muthukumar,''' and the complementary simulations by C.Y. Kong and Muthukumar."^
This theory put forth a criterion for adsorption of polyelectrolytes on oppositely charged
spheres and it can be best explained by equation (1.1). Equation (1.1) describes how the
effect of surface charge density, a, the charge on the polymer chain, q, the radius of the
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oppositely charged object, R, the Bjerrum length, ^ , the electrostatic persistence
length, /, , and the inverse Debye screening length, k, affects adsorption of a
polyelectrolyte onto a curved surface.
M^[,
-
.
-'^]> (1.1)
4 is the Bjerrum length (1.2)
(1.2)
In equation {\.2) e is the valence of the charge, c is the dielectric constant of the
solution and s^'x^ the permittivity in vacuum. In equation (1.1), /, is the electrostatic
Kuhn length defined in equation (1.3),
I
where (|/?"^ is the radius of gyration of the polymer in solution, (^')^ is the radius of
gyration of the polymer in theta conditions, /is the Kuhn length ( / = 2/^, ) and k is the
inverse Debye screening length which is related to the salt concentration (1.4).
Equation (1.4) is from the Debye-Huckel theory where C is salt concentration, n is
lomzation of the salt, and 8 is the dielectric constant." This proposed research aims to
gamer further information about if and how this theory may apply to the systems
studied in this research.
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1.3.3.2 The Effect of Persistence Length on the Adsorption of a Polyelectrolyte
onto a Charged Curved Surface
In the complexation of heterogeneous ribonucleoproteins to mRNA and histones
to dsDNA, understanding how persistence length, , influences protein adsorption is
non-trivial. What is interesting in dsDNA and mRNA is the similarity in these
polyelectrolytes' backbone repeating unit and location of charge their chemical
structure. The generic differences between these two polymers reside in an additional
hydroxyl group off the sugar in RNA and one pendent base (Uracil in RNA and
Thymine in DNA). From a global perspective, these differences are trivial. The most
important difference between these two macromolecules lies in the flexibility of their
backbone or their persistence length, . This difference in flexibility is attributed to the
DNA being double stranded while the RNA is single stranded.
In these studies. Hyaluronic Acid (HA) was used as the model polymer for
mRNA. HA is slightly more inflexible than RNA, with a persistence length of 4 nm"*^
compared to mRNA's persistence length which is cited as being 0.8 nm - 4 nm,
depending upon the ionic strength and experimental set up." While HA isn't as
flexible as mRNA, it is reasonably more flexible than dsDNA, which has a reported
persistence length between 40 nm and 80 nm," depending upon the experimental
conditions. Since dsDNA and mRNA play different roles within the cell, the goal of this
work is to understand how persistence length in these two model systems affects the
polymer-protein adsorption isotherms or if there are other factors influencing this
polyelectrolyte-protein isotherm.
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1.3.3.3 Current Kxperiniental Work on the Influence of Persistence Length on
Polyelectrolyte-Protein Adsorption
Little experimental work has been done on the effect of on protein binding to
polyelectrolytes. Two studies by Kaytimazer el al. have looked at four different
polymers: poly(dimethyldiallylammonium chloride) (PDADMAC), chitosan, a
copolymer of acrylamidomethylpropanesulfonate (AMPS) and acrylamide (AAm) and
hyaluronic acid. All polymers in these systems have bare persistence lengths,
,
between 2.5 nm and 6 nm. One study looked at the binding of cationically charged
micelles and protein serum albumin to the polyanions hyaluronic acid and AMPS/AAm
co-polymers. The other study investigated the complexation of negatively charged
micelles, dendrimers and bovine serum albumin to the polycations PDADMAC and
chitosan. In both papers, the of the more rigid polyelectrolyte is only twice the
stiffness of the other polymer, yet in each study a difference in protein affinity for each
polymer was observed. In comparison, for this investigation of the two systems with
HA-lysozyme and DNA-lysozyme, the two polyelectrolytes have a 5 to 10 fold
difference in persistence lengths. These studies were set forth to understand the effect of
persistence length and ionic strength on protein binding and to compare what has been
observed in literature to theory and simulations." "
Based on the formula by von Goeler and Muthukumar,' equation ( 1 . 1), it can be
seen that the binding of proteins is dependent upon surface charge density, o, inverse
Debye screening length, k, electrostatic persistence length, //, radius of the oppositely
charged surface, R, charge on the polymer, q, and temperature, T. These experiments
were designed in such a manner that each model polymer utilized had the same number
8
of charges on each polymer, q. HA and dsDNA have -8,000 negative charges per
polymer chain. The R of lysozyme is sufficient so that complexation is insured and the
temperature, T, of the system was held constant. In these studies the variables at hand
were the difference in persistence lengths between the two polymer chains, the charge
density on each of the polymer chains, and the effect salt has on the protein-polymer
binding isotherm of each system,
1.4 Conclusions
Complexation is an important phenomenon in our natural world. The goal of this
research is to further understand this event through three different cases of
polyelectrolyte complexation that are inspired by nature. Each of these complexation
events involves the adsorption of a polyelectrolyte onto an oppositely charged curved
surface and how different parameters influence adsorption. '
This research investigated a series of antimicrobial polycations and sought to
understand the factors that influenced antimicrobial activity through characterization of
the polymers in solution and how they interacted with biomimetic vesicles. This
collaboration explored how the local chemistry of the polyelectrolyte affected complex
formation and helped to further understand the variables that control antimicrobial
design. The other portion of this research investigated how the persistence length of a
polyelectrolyte played a role in the complexation of proteins using Hyaluronic Acid
(HA) and lysozyme, and dsDNA and lysozyme as model systems. These studies
explored the characteristics of the soluble aggregated state of the polymer-protein
systems and examined how ionic strength of the solution affected complexation. These
investigations focused on the role persistence length held in the polymer-protein
9
adsorption isotherm and sought to elucidate the underlying fundamentals that guided
these events. These studies revealed a variety of interesting and unexpected phenomena
which will help to advance the field of polyelectrolyte complexation in addition to
holding significance in other areas of biopolymer complexation.
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Figure 1.1: The Self Assembly of dsDNA into Chromosomes from the
Complexation of Histone Proteins and dsDNA.
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CHAPTER 2
ANTIMICROBIAL POLYMERS
2.1 Introduction
Host defense peptides found in nature have influenced some of the design
principles utilized for the development of synthetic antimicrobial polymers. Similar
design principles observed in antimicrobial polypeptides found in nature, such as the
amphiphilicity observed in helical cationic polypeptides have been utilized to design
synthetic molecules that have antimicrobial activity similar to host defense peptides. An
amphiphilic design was utilized by Coughlin and co-workers to develop a series of
antimicrobial polynorbornene derivatives.''^ "*^ In their studies, they varied the degree of
hydrophobicity of the pendent groups on the cationic polyelectrolytes, which resulted in
changes in the polymers' antimicrobial activity." These studies demonstrated that the
activity of these polymers was not as sensitive to molecular weight, Mw, variances
compared to minor changes in amino acid sequences of various host defense peptides.'
Characterization of these synthetic antimicrobial polymers and investigations of
polymer-biomimetic vesicle interactions were performed in order to further understand
the antimicrobial nature of these polymers.
The hydrophobic nature of these synthetic polymers appeared to play a
significant role in their antimicrobial activity. It was observed that as the
hydrophobicity of the pendent groups in polymers 1, 2 and 3 (Figure 2.1 ) was increased;
the minimum inhibitory concentration (MIC^o) decreased (Table 2.1). The MICgo is a
measure of the minimum amount of polymer necessary to inhibit ninety percent of
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bacterial growth. Although an improvement in antimicrobial activity was observed
between polymers 2 and 3 an increase in toxicity (or an increase in HCso) was also
observed. HCso is the concentration of polymer required for 50% red blood cell lysis.
This value is considered a measure of how toxic a substance is to human cells." Studies
of the co-polymer 2-co-3 have shown more favorable antimicrobial activity and
selectivity than previous homopolymers (Table 2.1). In addition to homopolymers 1-3, a
second series of random copolymers of hydrophilic and hydrophobic norbornene
derived monomers, Al, A4', and A12, (Figure 2.1 ), were synthesized to further explore
the use of copolymerization to tune biological activity.
In order to gain further understanding of how these synthetic polymers
mimicked host-defense peptides and further elucidate the mechanism of how they kill
bacteria, polymer-vesicle investigations with biomimetic vesicles were studied via DLS
and Confocal Laser Scanning Microscopy. These studies were pursued in order to
further understand the kinetics of binding and investigate the possible relationship
between an observed aggregation phenomenon and antimicrobial activity.
2.2 Experimental Section
2.2.1 Materials
All lipids were purchased from Avanti Polar-Lipids, TRfTONX-lOO
(polyethylene glycol p-(l,l,3,3-tetramethylbutyl)-phenyl ether),
dodecyltrimethylammonium bromide (DTAB), Sodium dodecyl sulphate (SDS) were
purchased from Aldrich; all were used without further purification. Buffer was made
from 150mM Sodium Chloride, lOmM Tris Hydroxymethylaminoethane and adjusted
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to pH 7.0 with HCl.
2.2.2 Synthesis, Characterization and Preparation of Antimicrobial Polymers
Modular norbornene amphiphilic polymers (Figure 2.1) were given to us from
Bryan Coughlin and Greg Tew's respective groups. The synthesis of these polymers can
be found in the literature. ''^ "^
2.2.3 Sample Preparations of Antimicrobial Polymers
2.2.3.1 Static Light Scattering (SLS) and Dynamic Light Scattering (DLS)
Characterization of Antimicrobial Polymers
Static light scattering measurements and dynamic light scattering measurements
were taken with a commercial light scattering spectrophotometer with an Ar laser ( =
514.5nm, 2W. laser power used for characterization 400mW) equipped with an ALV
5000 correlator. Characterization of the three antimicrobial polymers, 1, 2, and 3 were
made in the angular range 35-135 ° at 37°C. These measurements of the polymers were
taken in buffer solution with a dn/dc = 0.2. All polymers were assessed below overlap
concentration (c*) and a Zimm analysis was performed on the data.
2.2.3.2 Dynamic Light Scattering (DLS) Characterization of Antimicrobial
Polymers
Simultaneous dynamic light scattering measurements were carried out during
SLS characterization in the angular range 35-135 ° at 37''C. DLS measures the intensity
fluctuations of the scattered light and scattering centers in time. The autocorrelator
constructs an intensity correlation function for concentration fluctuations as given in
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equation 2. 1
:
^IS^t!}d(^t^ = gJr). 2.1
where q is the scattering wave vector defined in equation 2.2
q=4;r-sin(-) 2.2
A 2
n is the refractive index of the medium, X is the wavelength of hght in vacuum, and 0 is
the angle of the measurement. From the intensity fluxuations, the ALV software
constructs a nonlinear fit model given in equation 2.3:
g,{T)-\ = { \e "GiDdVf 2.3
Where G is the decay rate distribution function and Y is defined in equation 2.4:
r=i/T 2.4
And T is the relaxation time of the polymer. The diffusion coefficient can then be
determined from the relationship in equation 2.5:
r=Dq- 2.5
where q is the scattering wave vector. From this determination of D, if a polymer
system is a dilute, non-free draining regime (below c ) application of the Stokes-
Einstein relationship (equation 2.6) is valid and the hydrodynamic radius can be
calculated.
k T
D =-^^ 2.6
2.2.4 Preparation of Large Unilamellar Vesicles (LUV)
Vesicles with a POPE:POPG 3:1 (l-Palmitoyl-2-01eoyl-5M-Glycero-3-
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Phosphoethanolamine: 1 -Palmitoyl-2-01eoyl-5A7-Glycero-3-[Phospho-rar-( 1 -glycerol)]
(Sodium Salt)) composition were made by Greg Gabriel in Greg Tew's group and had
been prepared from a modified procedure from the literature.^
2.2.5 Vesicle Assays
The solution dynamics of the antimicrobial polymers with POPE/POPG vesicles
were monitored via Dynamic Light Scattering (DLS). A solution of POPE/POPG
vesicles 3:1 (4.175 x 10"^ M lipid concentration) in Tris buffer was monitored via DLS
at 600mW at 25°C and allowed to equilibrate in a xylene bath for approximately two
minutes before a sample of antimicrobial polymer (25 |a,l of a 0.454 g/L solution of
Polymers 1, 2, 3, 2-co-3, Al, A4', or A12) was injected into the buffered vesicle
solution. The power of the laser, 600mW, was such that the scattering intensity and
resultant correlation functions were solely from the scattering contributed by the
vesicles as the concentration of the polymer was too low to be detected at the laser
power of the experiment. After the sample was injected, DLS measurements were
taken in 5° angular increments from 35°-65° for 10 seconds at each angle for a total of
15 to 30 minutes.
2.2.6 Confocal Laser Scanning Microscopy
Rhodamine tagged vesicles (1 wt% ) were made by Greg Gabriel. Polymers 1, 2,
and 3 were added to respective solutions of vesicles and were left to interact with the
vesicles for a minimum time of 30 minutes before confocal images were taken with a
Leica Confocal Laser Scanning Optical Microscope. A 543nm wavelength was used to
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excite the Rhodamine tagged lipid and an appropriate filter was set up to capture
emission at 590nm.
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2.3 Results and Discussion
The main focus of this study was to utihze physical techniques to further
understand how synthetic antimicrobial polymers interact with phospholipid
membranes. Studies were pursued with phospholipid vesicles that mimic the charge and
composition of bacterial members. The goal of this study was to utilize these model
systems in order to further understand how these polymers kill bacteria.
2.3.1 Light Scattering Background
Light scattering is a common method used for characterizing polymers. From
static light scattering (SLS) and dynamic light scattering (DLS) a wide range of
physical characteristics can be determined. These studies were primarily concerned with
polymers in dilute solutions, below their overlap concentration, c . In static hght
scattering if a polymer system is below its overlap concentration a Zimm analysis
(equation 2.7) can be applied to the scattering information and polymer characteristics
such as molecular weight (Mw), radius of gyration (Rg), and second virial coefficient
(A2) can be determined:
where c is the polymer concentration, is the Rayleigh ratio, dn/dc is the refractive
index increment, Na is Avogadro's number, A is the wavelength of the laser (514.5nm),
n^oi is the refractive index of the solvent, and q is the scattering wave vector defined in
equation 2.2.
(2.7)
K = An-n^Jidnl dcf (2.8)
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2.3.2 Dynamic Light Scattering of Antimicrobial Polymers
Dynamic light scattering yields information about the polymer dynamics of a
system. What is fascinating about polyelectrolytes is that they show unexpected
behavior in different salt conditions which can be monitored by DLS. Polyelectrolytes
are highly charged polymers and due to charge-charge repulsion along the chain it is
somewhat unexpected to see aggregates of these highly charged species. What is
interesting is that even though polyelectrolytes are highly charged, in low salt
conditions these polymers demonstrate two modes a 'fast' mode and a 'slow* mode.
The 'fast' mode is related to the diffusion of the counter ion and the backbone of the
polymer chain, while the 'slow' mode is due to the clustering of these highly charged
polymer chains. From DLS. a diffusion coefficient can be determined for this 'fast'
mode which is the coupled diffusion of the counter-ion and the backbone of the
polymer. As this 'fast' mode is not a measure of the single polymer chain dynamics,
application of the Stokes-Einstein relationship is not applicable. Calculating an Rh for
the 'slow' mode is reasonable as the hydrodynamic radius is proportional to the cluster
size of the aggregate. What has been found in the polyelectrolyte literature is that with
an increase in salt these 'slow' mode, 'fast' mode dynamics disappear and a single
mode will remain.''^
In this study, the 'fast' mode dynamics of the counter-ion and the polymer
cluster were reasonably difficult to discern due to the diffusive nature of the interaction.
During the data analysis it was possible to observe some fast mode dynamics and
observe some q" dependent relaxation, yet during much of the analysis it was difficult to
see a q" dependent fast mode dynamics making it difficult to determine the diffusion
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coefficient for the co-diffusion of the counter-ion and the polymer backbone. Generally
the fitting for the diffusion coefficient for the 'fast' mode was not as good compared to
the fittings for diffusion for the 'slow' mode that was from the polymer aggregates
(Figure 2.2 and Figure 2.3).
For the DLS characterization of polymers 1, 2, and 3 the resolution and fitting
of the correlation function of the 'slow' mode yielded good fits in high salt (150mM
NaCl, lOmM Tris) salt and low salt (OmM NaCl, lOmM Tris) conditions. Figure 2.4
shows a typical correlation function for the slow mode for polymer 3 in no monovalent
salt conditions. Figure 2.5 shows a distribution function determined from a CONTIN fit
of the correlation function. From these analyses both the slow and fast modes can be
determined (Figure 2.2 and Figure 2.3).
From the analysis of the 'slow' mode, it was observed that all antimicrobial
polymer samples under all measured salt conditions tended to aggregate. The aggregate
size appeared to be independent of salt condition and was seen that with polymer 3 the
aggregate size actually increased in the higher salt conditions (Figure 2.6). This increase
in aggregate size was due to the fact that with an increase in salt the electrostatic
repulsive interactions were screened for the polymer aggregate, thus the hydrophobic
interactions along the pendent groups became more dominate which increased the
tendency of the polymer chains to aggregate.
2.3.3 Static Light Scattering
From a Zimm analysis of the SLS data, aggregation of the polymers in both high
and low salt conditions for polymers 1, 2, and 3 was confirmed. In Figure 2.7
aggregation of the polymer chains was apparent due to the observed increase in
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intensity at low angles which was observed as a down turn in the scattering at lower
angles. The molecular weights of polymers with T-boc protected cationic groups from
gel permeation chromatography (GPC) data in tetrahydrofuran (THF) are listed in Table
2.1. Once the cationic groups of the polymer chains were deprotected and were in an
aqueous environment, aggregation was observed in high and low salt conditions. Due to
this aggregated behavior, interpretation of the SLS data was more complicated.
Further analysis of the low q region to interpret the molecular weight of the
aggregated clusters still did not yield satisfactory results. The SLS data on polymer 2 in
150mM NaCl, lOmM Tris (Figure 2.7) showed a downturn in Kc/R at in the low q"
region which indicated aggregation. Further analysis of the lower angular region did not
yield a reasonable molecular weight compared to the Rg and Rh of 84 nm and 65 nm
respectively. This inability to determine a reasonable molecular weight may be due to
the fact that there was not enough data at lower q^ values, or that the dn/dc of the
aggregate was sufficiently different than that of the bulk solution. The molecular weight
information that was yielded from the SLS data confirmed the aggregated state of the
polymer chains which was supported by the DLS information.
2.3.4 Polymer-Vesicle Studies
Desiring to further understand how antimicrobial polymers interacted with and
killed bacteria, we employed the use of biomimetic vesicles to further study this
interaction. These vesicles, albeit much smaller than bacteria, were made from similar
phospholipids (POPE:POPG, POPE = l-Palmitoyl-2-01eoyl-^A/-Glycero-3-
Phosphoethanolamine: POPG = l-Palmitoyl-2-01eoyl-5^n-Glycero-3-[Phospho-rac-(l-
glycerol)] (Sodium Salt))and contained the same neutral to anionic charge ratio (3:1) as
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what is observed in bacterial membranes. As this study was focused on the interaction
of the cationic antimicrobial polymer with the outer bacterial membrane, it was
reasonable to ignore the design of the inner membrane of bacterial cells for this model.
Fluorescent dye leakage studies were previously done with these antimicrobial
molecules and biomimetic vesicles. These studies demonstrated that membrane
disruption occurred upon the addition of antimicrobial molecules, yet no further
information about the state of the membrane had been determined from those
experiments. It was not known if these antimicrobial polymers disrupted the membrane
yet left it relatively intact (as what had been observed with peptides that form pores), or
if the polymers completely destroy the membrane displaying detergent-like action.
Kinetic studies with DLS tracked the dynamics of the vesicles upon addition of the
polymer and gave further insight into how the antimicrobial molecules interacted with a
model of the outer membrane of a bacterial cell.
2.3.4.1 Polymer-Vesicle Studies with DLS for Polymers 1, 2, and 3
For the polymer-vesicle studies it was observed that Triton-X, a known
membrane detergent at high concentration (0.2%), destroyed all the vesicles in less than
two minutes. This was confirmed with DLS as after two minutes as loss of correlation
of from the vesicles was observed. The time leading up to full dissolution of the vesicles
was unable to be interpreted due to the speed at which the vesicles were destroyed.
Experiments with cationic surfactant DTAB (dodecyltrimethylammonium bromide,
0.2%) and anionic surfactant SDS, (Sodium dodecyl sulphate, 0.2%), showed no change
in vesicle size with time. By contrast to these surfactants, polymer 3, a cationic
antimicrobial polymer, did induce a change of vesicle size with time (Figure 2.8). It is
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believed that part of the reason the cationic surfactant DTAB did not show any change
in size of the vesicle was due to the fact that surfactant molecules are not linked
together with many charges on one chain like what is seen with the antimicrobial
polymers. A DLS vesicle study interaction with host defense peptide gramicidin S and
an analogue of this peptide indicated that the presence of the antimicrobial peptide does
not induce any changes in the vesicle size. In that study, no fusion of the vesicles under
the experimental conditions were observed as there was no observed change in Rh with
time. Our findings with this series of polymers was quite different than what was
observed with the host defense peptide gramicidin S or analogues therein, as
aggregation of the biomimetic vesicles was observed upon addition of the antimicrobial
polymers. Our findings led us to hypothesize that the mode of action for these
antimicrobial polymers was different than what had been observed with the peptides in
the previous study.
Table 2.1 shows the varying degrees of antimicrobial activity for polymers 1, 2,
and 3 and the corresponding molecular weights determined by t-boc protected GPC in
THF. Polymer 2 showed a reasonable amount of antimicrobial activity with a MIC90 of
200}jg/mL and 300fig/mL against E.coli and B.suhtilis, while polymer 3 showed good
antimicrobial activity against these two bacteria with MIC90 of 25|ig/mL. DLS showed
aggregation for both of these systems. Yet polymer-vesicle studies with 1, which had no
antimicrobial activity with a MIC90 value of >500 |ig/mL, showed no aggregation of the
vesicle systems after the addition of the polymer (Figure 2.9).
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2.3.4.2 Polymer-Vesicle Studies with Polymers 1, 2, and 3 and Confocal
Microscopy
The aggregation of the antimicrobial polymers and vesicle systems continued
beyond 30 minutes as shown in Figure 2.9, but the size limitations of DLS was met
around Rh values of 600-700nm when there was a loss of q" dependence in the analysis.
For studies beyond thirty minutes, vesicle-polymer aggregation was visualized with
Confocal Laser Scanning Microscopy by tagging lipids with Rhodamine. Aggregation
of the vesicles (Rh of vesicles without polymer =120 nm) with 1, 2, and 3 was observed
after 30 minutes (Figure 2.10). Recently, studies with fluorescently labeled S.aureus
and antimicrobial polymers 1, 2, and 3 have shown aggregation of the live bacteria.
These studies confirmed that these biomimetic vesicles used for other parts of this
research are good bacterial models. ''^
2.3.4.3 Polymer-Vesicle Studies with Polymers 29-3i, Al, A4' and A12
While polymer 3 has excellent antimicrobial activity, it also demonstrated a
significant amount of red blood cell lysis which is an indicator of toxicity to human
cells. Further pursuits of other polymers were explored by the Tew group that would be
both antimicrobial yet less toxic to humans. Random co-polymerization of polymers 2
and 3 was pursued which did show less toxicity than polymer 3 but its antimicrobial
activity, though still good, was not as efficient as polymer 3 (Table 2.1).
Further investigations into the role of hydrophobicity and the placement of the
hydrophobic and cationic groups were explored with copolymers Al, A4' and A 12
(Figure 2. 1 ). Each set of co-polymers had differing amounts of hydrophobic pendent
groups on one of the co-monomers. It was discovered that the amount of hydrophobicity
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in the polymer must be fine tuned in order to yield a polymer with antimicrobial
activity. Not enough hydrophobic nature, as in the polymer Al case, or too much, as
with polymer A12 resulted in little antimicrobial activity (Table 2.1). Polymer A4'
showed that the placement of the hydrophobic group in relation to the cationic group
does play somewhat of a role in the antimicrobial activity, as polymer A4' is a co-
polymer of the hydrophilic and the hydrophobic components of the monomer that
makes up polymer 3. While the activity of polymer 3 appeared to be independent of
molecular weight, polymer A4' showed sensitivity to molecular weight with the higher
molecular weight polymer showing less efficiency in killing bacteria compared to its
lower molecular weight analogue. What was found with these copolymers in
comparison to our studies with homopolymers 1, 2 and 3 was that the copolymers that
had some amount of antimicrobial activity, similar to polymer 2 or better, also induced
aggregation of the vesicles (Figure 2.1 1). High and low molecular weight polymers of
2-C0-3 and A4"' all showed MICqo data that was similar to polymer 2 or better. From the
DLS analysis they also induced an apparent aggregation of the vesicles (Figure 2.1 1 and
2.12).
This study mainly focused on how hydrophobic pendant groups influenced the
antimicrobial activity of synthetic polymers. It was concluded from these studies that if
a polymer had too little of a hydrophobic character (for example what was seen with a
single CH3 group in polymer Al) in a pendent group or too much of a hydrophobic
character (as seen with a 12 carbon pendent group in polymer A12) a polymer would
not yield any measurable amount of antimicrobial activity. This indicated that the
amount of hydrophobic character of a polymer is important in order to illicit
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antimicrobial activity. Too much or too little hydrophobic character will negatively
impact a polymer's ability to kill bacteria. The use of biomimetic vesicles proved to be
a useful model that gave insight into how these polymers interacted with membranes
similar to those found bacteria. For this study of polymers, aggregation appeared to be
necessary in order for moderate to good antimicrobial activity to be observed.
Aggregation appeared to be an important component of antimicrobial activity, but it
does not appear to be the only factor necessary for exceptional antimicrobial activity
which is defined as an MIC90 < 50|ag/mL.
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2.4 Conclusions
• Antimicrobial polymers characterized by SLS and DLS showed aggregation in
high and low salt solutions.
• Aggregation of polymer molecules was due in part to hydrophobic interactions
as an increase in aggregate size was observed when electrostatic repulsive
interactions were screened with an increase in ionic strength in the solutions.
• Antimicrobial activity was not due to complete solubilization of the bacterial
membrane as aggregation of biomimetic vesicles was observed over time.
• Biomimetic vesicles used in this study were sufficient models as similar
aggregation results have been seen with live bacteria and some of the polymers
used in this study.
• Interestingly other studies with host defense peptides and analogues therein did
not see any change in Rh with DLS. Thus, aggregation appeared to be an
indicator of antimicrobial activity for this series of polymers.
• While aggregation appeared to be a significant indicator of antimicrobial activity
in these polymers, aggregation by itself is not necessarily sufficient to elicit
antimicrobial activity.
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Table 2.1: Antimicrobial and Hemolytic data for Polymers Used in these Studies.
Data for Polymers 1, 2 and 3 at 60,000 (g/mol) was been previously
determined" and all other antimicrobial data was done in collaboration
with the Tew group. All molecular weights calculated here were from
GPC in THF with the cationic groups on the polymer T-boc protected.
Polymer M„ MIC MIC MIC HC50
(g/mol) E. coli B. subtilis S. Aureus (Ug/mL)
(ug/mL) (ug/mL) (ug/mL)
1 60.000
2 60,000 200 200 n/a >4,000
3 60,000 80 80 n/a <1
1 10,000 >500 >500 400 >1000
2 10.000 200 300 100 >4,000
3 10,000 25 25 15 <1
29-3, 9,600 50 n/a 100 >4,000
Al 14,000 >400 n/a 400 2150
A4' 15.100 200 n/a 200 50
A12 14,800 >400 n/a 400 <50
Al 3,300 400 n/a 400 2150
A4' 3,400 50 n/a 50 50
A12 3,700 400 n/a 75 <50
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Figure 2.1: Antimicrobial Polymers Used for this Study: 1, 2, 3, 2-co-3, Al, A4'
and 12
30
7x10^
n
D(7g/]) = 5.8 E-12 ± 7.4-14 mVs Rh = 57 nm
D(3.5g/1)= 5.4 E-12 +6.1E-14m7s Rh = 62nm
D (1.75 g/l) = 5.4 E-12 ± 7.5E-14 m7s Rh = 62nm
D (0.875 g/1) = 5.5 E-12 ± 6.3E-14 m7s Rh = 62 nm
7g/l
• 3.5 g/1
1.75 g/l
0.875 g/1
6x10'-
5x10 -
4x10 -
3x10 -
2x10 -
1x10 -
4.0x10 6.0x10 8.0x10 1.0x10
q" (m"
Figure 2.2: DLS Analysis of 'Slow Mode' dynamics for Polymer 3 (OmM NaCI,
lOmM Tris, pH 7, 37°C)
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;ure 2.3: DLS analysis of 'fast mode' dynamics for Polymer 3 (OmM NaCl,
lOmM Tris, pH 7, 37°C)
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Figure 2.4: An Example of a Typical Correlation Function for Polymer 3 (OmM
NaCI, lOmM Tris, pH 7, 37°C)
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Figure 2.5: An Example of a Distribution Function from CONTIN analysis for
Polymer 3 (OmM NaCl, lOmM Tris, pH 7, 37°C)
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Figure 2.6: Summary of Rh Determined from DLS for Polymers 1, 2 and 3 in High
and Low Salt Conditions
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Figure 2.8: DLS Studies of Vesicle with Surfactants and Polymer 3
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;ure 2.9: Polymers 1, 2 and 3 Vesicle Studies of Aggregation with Time
i
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Figure 2.10: Confocal Images of Vesicles with Polymers 1 (a), 2 (b), and 3 (c).
Scale Bars Represent 40(im.
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Figure 2.11: Polymer-Vesicle Studies with Higher Molecular Weight Polymers Al,
A4% A12 and 2-co-3
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Figure 2.12: Polymer-Vesicle Studies with Lower Molecular Weight Polymers Al,
A4'and A12 and Random Copolymer of 2-co-3
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CHAPTER 3
COMPLEXATION OF POLYELECTROLYTES AND LYSOZYME
3.1 Introduction
Various studies into the diverse facets of polyelectrolyte-protein complexation
have been pursued over the years. Polyelectrolytes have been used for decades in
biotechnological preparations to isolate proteins, ^'^ and recently polyelectrolyte -protein
complexation has been used as a means of creating nano-particles for drug delivery.
Many studies have focused on the onset of complexation, while others have explored
the rich of phase behavior of polyelectrolyte-protein complexation.
Polyelectrolyte-protein phase behavior has been explored since the beginning of
the 20"^ century. In the 1930s, Brudenberg observed a new type of phase behavior with
polyelectrolytes and proteins that he called a complex 'coaceravate'.^^ In non-technical
terms, a coacervate is defined as an aggregate of colloidal droplets held together by
electrostatic attractive forces.'^'^ A few examples of polyelectrolytes and proteins that
were observed to form coacervates in more recent literature are bovine serum albumin
and poly(diallyldimethylammonium chloride)'^'' and the complexation between whey
proteins and gum arable."^ Other complexation studies with polyelectrolytes have
explored how multivalent curved charged surfaces, like multivalent ions and proteins,
induce phase separation. ^^'^^
Biologically important polyelectrolytes like DNA and RNA frequently complex
with proteins in nature. DNA-histone complexation is necessary for the compaction of
DNA into chromatin and eventually into chromosomes. Messenger RNA, mRNA, can
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complex with a variety of proteins and siiuttle these proteins between the cytosol and
the nucleus in the form of hnRNP complexes. From a global perspective these two
biopolymers predominantly differ in their persistence lengths, Ip, and charge densities.
Designing model systems that are much simpler than dsDNA-histone and hnRNP
complexes would provide insight into how these parameters affect complexation with
proteins in general.
For the polyelectrolyte-protein studies set forth in this research, circular double-
stranded DNA and Hyaluronic Acid were employed in order to compare and contrast
two polyelectrolytes whose persistence lengths differ by an order of magnitude, with
DNA's persistence length on the order of 40-50 nm" and HA's persistence length
1(1)
approximately 4 nm." The two polymers also differ in charge density, with DNA's
helical charge density -0.2 charges/nm^^ and HA's charge density is -1.5 charges/nm .
These two polymers were selected in order to clearly determine how Ip and charge
density influenced complexation. Lysozyme was utilized as a model protein in this
study due to its high isoelectric point of 1 1 and +8 charge at pH 7.^^ While these
studies focused on the effect of persistence length and charge density on the formation
of soluble complexes and the subsequent phase behavior of the two systems, ionic
strength was also varied to see how it influenced this complexation as the
polyelectrolyte-protein interactions in these systems were considered to be
predominately electrostatic. From these two model systems, further understanding was
garnered of the various parameters that influenced complexation between these
polyelectrolytes and proteins.
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3.2 Experimental
3.2.1 Materials
Hyaluronic acid was purchased from Sigma-Aldrich (Fluka). Circular double-
stranded DNA was made from a standard bacterial extraction kit and all solutions
pertaining to the extraction were included (PhonlX^'^ Maxiprep Kit Qbiogene). Egg-
white lysozyme was purchased from Sigma-Aldrich and used without further
purification. All other chemicals were purchased from Sigma-Aldrich. All solutions
were made with MiUi-Q water (Milhpore USA).
3.2.2 Preparation of Circular Double Stranded DNA
A strain of E.Coli that had been transfected with the plasmid pBluescript SKII(-)
was received from Nick Hud's group at Georgia Tech. This bacterium was cultivated
and the circular double stranded DNA plasmid was extracted with the aid of a Phoenix
Maxiprep kit (qBiogene). A starter culture in 5mL of Luria-Bertani (LB) with 10|il
ampicillin (50mg/ml) was inoculated with E.coli that had the plasmid pBluescript
SKII(-). The day culture was incubated at 37°C at 250 rpm for 6-8 hours. An overnight
culture in 200mL of LB was prepared using 400|li1 of the starter culture and 400)li1 of
Ampicillin. The overnight culture was incubated at 37°C at 275 rpm for 16-18 hours.
The next day equilibration buffer (30mL of 600mM NaCl, lOOmM sodium acetate pH
5.0, 0.15% Triton® X-100) was added to the extraction column (an ion exchange
column) and left to elute. The overnight culture was spun down at 6,000 x g at 4°C for
1 5 minutes and the supernatant was then removed from the pellet. All pellets were re-
suspended with cell resuspension buffer (lOmL of 50mM Tris HCl, pH 8.0, lOmM
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EDTA with RNase) and pooled together. Lysis buffer (lOmL of 200mM NaOH, 1.0%
SDS (w/v)) was added to the pooled pellets and incubated for 5 minutes at room
temperature. Neutralization buffer (lOmL of 3.1 M potassium acetate, pH 5.5) was
added to the pooled pellets and the sample was mixed until it was considered
homogeneous. The mixture was centrifuged at 12,000 x g for 15 minutes at 4°C. The
cleared lysate was separated from the mixture and was left to warm to room temperature
before addition to the column. Once the supernatant was warmed to room temperature,
it was put on the column and the eluted liquid was discarded. Column wash buffer
(60mL of 800mM NaCl, lOOmM sodium acetate. pH 5.0) was added to the column and
left to elute. After the column wash buffer had eluted, a centrifuge tube was placed
underneath the column and elution buffer (15mL of 1250mM NaCl, lOOmM, Tris pH
8.5) was added to the column and the eluted DNA was collected. Isopropanol (10.5mL)
was added to the eluted buffer solution and the mixture was left overnight in the freezer
to precipitate. The isopropanol-eluted DNA buffer mixture was centrifuged at 12,000 x
g at 4°C for 30 minutes. The supernatant was poured off and ethanol (70%, 5mL) was
added to wash the pellet and then centrifuged at 12,000 x g, 4°C for 5 minutes. The
supernatant was removed and the DNA pellet was left to dry. The precipitated DNA
was re-suspended in lOmM Tris, pH 7. DNA concentration, purity and integrity were
confirmed via UV-Vis and gel electrophoresis. Only DNA extractions with UV ratios of
DNA to protein (X = 260 nm/280 nm) greater than 1 .7 were used in the experiments.
3.2.3 Sample Preparation
All tubes were cleaned with a 1-2% solution of detergent and sonicated for an
hour. The tubes were rinsed with MilliQ water, rinsed with acetone, and dried with
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nitrogen before capping. Buffered polymer solutions were then added to the clean tubes.
Stock solutions of lysozyme were dissolved in various salt solutions (OmM NaCl with
lOmM Tris, pH 7; ImM NaCl with lOmM Tris, pH 7; lOmM NaCl with lOmM Tris,
pH 7 and lOOmM NaCl with lOmM Tris. pH 7) and filtered. The stock protein
concentration was confirmed by UV-Vis 'dtX = 260 nm (molar absorption coefficient of
3.6 M 'cm ').^'^ Different concentrations of protein solutions were added to the polymer
solutions. All polymer-lysozyme mixtures were left to equilibrate for a minimum of five
days.
3.2.4 Static and Dynamic Light Scattering Experiments
Simultaneous static and dynamic hght scattering measurements were taken with
a commercial light scattering spectrophotometer using an ALV goniometer (ALV,
Langen Germany) with a 2W Ar laser (Aq =514.5 nm) equipped with an ALV 5000/E
correlator with 288 channels. Most measurements were taken at 20mW. SLS and DLS
data was collected between angles 35° and 65° at 5° increments and from 70° to 90° in
10° increments. Correlation functions were analyzed with ALV software using a
CONTIN analysis in the same manner as in Chapter 2.
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3.3 Results and Discussion
3.3.1 Complexation of a Semi-Flexible Polymer and Lysozyme
3.3.1.1 Phase Behavior of DNA-Lysozyme
This work focused on understanding the equilibrium phase behavior of a DNA-
lysozyme system and how it compared to other studies of polyelectrolyte-protein
complexation and phase behavior. This study investigated the phase diagram of a
polymer-protein complex that consisted of double stranded DNA (8,000 bp) and
lysozyme. DNA is a semi-flexible polymer with a persistence length, Ip, of -SOnm" ' .
DNA is considered a strong polyelectrolyte with its charge not affected by pH and has a
high charge density with a negative charge every 0.2 nm.^^ Lysozyme is a basic protein
with a high isoelectric point of pH 1 1^'and a net +8 charge at pH 7, with its basic
charges evenly spread over its surface. The molecular weight of lysozyme is roughly
14,600,-'" but at pH 7 one study observed monomer-dimer equilibrium indicating Mw of
17,000 g/mol.^' This observation indicated that while there is some equilibrium between
monomer and dimer formation, the protein is predominately a monomer.
This study explored the phase diagram of DNA-lysozyme complexation at pH 7.
The goal of this investigation was to understand how DNA concentration, lysozyme
concentration, molar charge ratio between the two biopolymers and ionic strength of the
solution influenced the phase diagram. Molar charge ratio of a complex refers to the
ratio between the moles of negative charge contributed to a mixture by DNA (8,000
negative charges per molecule of DNA) compared to the moles of positive charge
contributed by lysozyme (-1-8 per molecule of lysozyme at pH 7).
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Based on the molar charge ratio of the DNA-lysozyme complexes, the phase
diagram is divided into two regions delineated by a solid black line as seen in Figure
3.1. Above the line, the moles of negative charge from the DNA backbone are in excess
and below the line the moles of positive charge from lysozyme are in excess (based on a
monomer of lysozyme contributing +8 charges). The samples made for this study were
considered equilibrium observations as the complexes had five days to equilibrate after
sample preparation. It appeared that the manifestation of insoluble complexes partially
depended upon the absolute polymer-protein concentration in the mixture. The
conditions explored in this study yielded regions of soluble complexes and insoluble
complexes in all salt conditions (Figure 3. 1 ). Samples in all ionic strength solutions
produced four types of mixtures: phase separated with a precipitate, a clear mixture with
homogenous soluble complexes, a meta-stable mixture that yielded a homogeneous
mixture upon agitation and a clear mixture with inhomogeneous complexes that resulted
in poor correlation functions(Figure 3.2).
For samples that yielded homogeneous scattering, detennination of the size of
the soluble complex was possible. The samples with homogeneous scattering generated
good correlation functions (Figure 3.3) and a good fit for the calculation of the diffusion
coefficient (Figure 3.4). Since these complexes were considered non-free draining, the
Stokes-Einstein relationship (equation 2.7) was utilized for the determination of the
hydrodynamic radius, Rh- The hydrodynamic radii of all soluble complexes over all
ionic strengths for which a value could be calculated are listed in Figures 3.5, 3.6, 3.7
and 3.8.
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3.3.1.2 Effect of Ionic Strength on the Phase Diagram of DNA-Lysozyme
Complexes
Intra-particle electrostatic screening was observed in the DNA-lysozyme phase
diagrams of OmM to ImM to lOmM of NaCl. A broadening of the phase boundary can
be observed with an increase in ionic strength. It can be seen in Figure 3.1 that certain
samples at low ionic strength had phase separated precipitates, yet as the concentration
of NaCl increased from OmM to ImM and lOmM a screening of the electrostatic
interactions that had previously contributed to phase separation at OmM NaCl DNA,
now allowed for soluble aggregates to be characterized by DLS. (For example DNA-
lysozyme complex: DNA = 0.01 8g/L and lysozyme = 0.005g/L in Figure 3.1 (a), (b)
and (c)). In this case, the samples under low-salt conditions contained an insoluble
precipitate, yet as the ionic strength of the mixtures was increased, a screening of the
inter-particle electrostatic interactions allowed for the formation of homogeneous
soluble complexes at the higher ionic strengths. At higher ionic strength it became
possible to determine the Rh of the complexes. A broadening of the phase boundary
with increasing NaCl concentrations up to lOmM NaCl augmented the total amount of
polymer or protein necessary for phase separation (Figure 3.1). This broadening of the
phase boundary up to lOmM NaCl succumbed to another phenomenon at the highest
ionic strength evaluated, lOOmM NaCl.
At low enough DNA or lysozyme concentrations the added salt contributed to
intra-particle screening, hence mixtures that had been phase separated at OmM NaCl
yielded soluble complexes at lOOmM NaCl, but this was not the situation for all
samples that had shown soluble complexes at lOmM NaCl. An increase in the addition
of monovalent salt appeared to have turned what was considered a 'good" solvent for
49
this charged system into a 'poor' solvent and the complexes were 'salted out" ol"
solution. This phenomenon of 'salting out' has been studied and utilized to precipitate
polyelectrolytes for decades. Some polymer-protein samples in this study that
contained clear homogeneous soluble complexes atlOmM NaCl had a precipitate at
lOOmM NaCl (Figure 3.1, DNA 0.01 8g/L: lysozyme 0.005 g/L). High concentrations of
monovalent salt solutions are commonly utilized in biological preps to precipitate
polyelectrolytes so it is not surprising to see a 'salting out' of these polyelectrolyte-
protein complexes at higher monovalent salt concentrations. Even though an increase in
monovalent NaCl affected the boundaries where phase separation occurred, the increase
in salt only influenced the region in which the molar charge ratio of the complex
favored DNA. The region in which lysozyme 's molar charge ratio was in excess (below
the solid black lines in all phase diagrams) was unaffected by ionic strength. DLS
measurements for mixtures in these regions at all salt concentrations, yielded low
inhomogeneous scattering. For DNA-lysozyme complexation to yield homogeneous
soluble complexes this study concluded the absolute DNA or protein concentration
must not be too high, the molar charge ratio of the complex must favor DNA and the
ionic strength of the solution must be considered 'good' for the DNA-lysozyme
complex.
3.3.1.3 Dynamic Light Scattering of DNA-Lysozyme Complexes
The DLS average size analyses of the DNA-lysozyme complexes are shown in
Figure 3.9 and Figure 3.10. Over all salt concentrations, DNA-lysozyme soluble
complexes ranged in Rh from 168 nm to 650 nm, with the average size
being 286 ± 5 Inin . From the calculations of Rh, the DNA-lysozyme complexes near the
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phase boundary were larger compared to the soluble complexes that formed away from
this boundary (Figure 3.5, DNA O.005g/L:lysozyme 0.01 g/L (650 nm) compared with
DNA O.005g/L:lysozyme 0.005g/L (240 nm)).
In low salt conditions, OmM NaCl, the 0.005g/L DNA: 0.005g/L lysozyme
complex was considered away from the phase boundary and yielded a soluble complex
with an Rh of 240nm. Yet when the protein concentration was doubled to 0.01 g/L, a
dramatic increase in aggregate size (650 nm) at low ionic strength was observed. This
much larger complex resided on the soluble side of the phase boundary and as the
protein concentration increased to 0.015g/L phase separation was observed (Figure 3.5).
Analysis of the aggregates away from phase boundaries confirmed a smaller average
size over all salt concentrations of 235 ± 12/;w (Figure 3.10). The average Rh of the
DNA-lysozyme complexes away from the phase boundary showed a spontaneous
selection of size of about ~235nm at a variety of polymer, protein and salt
concentrations. This was an outstanding observation. Amazingly when an aggregate
mixture did not border a phase boundary, the average size of the DNA-lysozyme
complex was not profoundly influenced by polymer, protein or monovalent salt
concentration!
3.3.2 Complexation of a Flexible Polyelectrolyte and Lysozyme
3.3.1.1 Phase behavior of Hyaluronic Acid (HA)-Lysozyme
In order to understand the influence of persistence length, Ip, on polyelectrolyte-
protein complexation, a phase diagram was constructed with Hyaluronic Acid (HA) and
lysozyme samples at various ionic strengths and polymer-protein concentrations. HA is
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a polyelectrolyte with a smaller persistence length (4 nm" ) and a lower charge density
(one charge per 1.5nm) than dsDNA. This study with HA and lysozyme was designed
such that the total number of moles of negative charges contributed by HA molecules
for a given complex was equal to the number of moles of negative charge that DNA
molecules contributed for a corresponding complex on the DNA-lysozyme phase
diagram. HA used in this study had approximately the same number of negative charges
per polymer chain as the DNA utihzed in the other study (-8,000). At a OmM NaCl,
lOmM Tris buffer, pH 7 solution, HA-lysozyme showed a different phase diagram than
the DNA-lysozyme complexes (Figure 3. 11). For the same polyelectrolyte molar charge
contribution and the same concentrations of lysozyme (which led to phase separation in
the DNA system) phase separation was not observed in the HA system. In contrast to
dsDNA-lysozyme studies, the formation of homogenous complexes of HA-lysozyme
occurred even when lysozyme' s molar charge ratio was in excess (Figure 3.11).
Interestingly, no phase separation was observed for the HA-lysozyme complexes in the
same concentration and molar charge ratio regimes (up to 0.01 Ig/L HA and up to
0.03g/L of lysozyme) as what had been observed in the DNA-lysozyme phase diagrams.
In order to locate the inception of phase separation in the OmM samples (Figure
3.11) for the HA-lysozyme system, the concentrations of the HA and lysozyme was
increased. The calculated Rh values near the phase boundary for HA-lysozyme
complexes in the soluble region showed an increase in aggregate sizes near the phase
boundary (Figure 3.12, i.e. HA 0.1 Ig/L and lysozyme 0.12g/L). This was similar to
what had been observed in the DNA-lysozyme samples. In the DNA-lysozyme phase
diagram it had been observed that the soluble aggregates' Rh was larger for samples that
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bordered the phase boundary. At high enough HA and lysozyme concentrations, phase
separation ensued producing mixtures with white precipitates (Figure 3.1 1 ). While this
study was not focused on determining the mechanism of phase transitions in these two
systems, the precipitate observed for the HA-lysozyme complexes was visually
different than what had been observed for the DNA-lysozyme complexes. Whether the
phase separation observed was via the same mechanism with different visual
appearances is unknown and would be an important investigation for future studies.
The HA-lysozyme samples yielded different regions of precipitates compared to
the DNA-lysozyme precipitates. The HA-lysozyme phase diagrams in low salt (OmM
NaCl, lOmM Tris, pH 7; Figures 3.1 1 and 3.12) showed a wider range of metastable
samples. These are shaded in grey in Figures 3. 1 1 and 3.12. In the DNA-lysozyme
complexes, one indication that a sample resided near a phase boundary was the
observation of a larger Rh for the complex. HA-lysozyme samples near the phase
boundary appeared to have a metastable nature as the supernatant still maintained a
complex rich phase that was homogenous enough to determine the Rh of the complexes,
yet upon observation of the bottom of the sample holder a precipitate could be seen. The
HA and lysozyme concentrations were increased until phase separation occurred
yielding a complex rich precipitate and a complex poor supernatant. This is denoted
with a black filled in circle in the phase diagram in Figure 3.12.
Homogeneous soluble aggregates in the HA-lysozyme system only appeared
near the molar-charge ratio boundary when these complexes' molar charge ratio
bordered 1:1. If the molar charge ratio excessively favored either HA or lysozyme the
resulting samples yielded clear mixtures that contained inhomogeneous scattering and
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thus no size information could be determined for these regions. These samples are
denoted in figure Figures 3. 11, 3.12, 3.13 and 3.14 as the circles with blue stripes. For
regions of lower HA-lysozyme concentrations the cause of this inhomogeneous
scattering was not well understood.
In samples with higher HA-lysozyme concentration that had a molar charge
ratio that favored lysozyme, a visually different precipitate manifested (dotted circles in
Figures 3. 1 1 and 3.12) compared to the phase separated regions where the molar charge
ratio favored HA. When the molar charge ratio favored lysozyme the precipitate that
was observed was difficult to see due to its refractive index being similar to that of the
glass. These mixtures yielded a complex poor supernatant and no size information could
be determined. It has been concluded that this type of phase separation may have
occurred for samples with a molar charge ratio favoring lysozyme at lower
concentrations, but were too dilute for visual observation and the hence the mixtures
yielded inhomogeneous scattering. When phase separation was observed in complexes
that the molar charge ratio favored HA (HA = 0.25g/L, lysozyme = 0.24g/L) the
observed precipitate at the bottom of the sample holder was a white precipitate
compared to the clear precipitate observed when the molar charge ratio favored
lysozyme (filled in black circle in Figures 3.1 1 and 3.12). It is interesting to note the
different visual manifestations of the precipitates. Future studies into what dictates these
differences would be beneficial to further the understanding of complexation and its
associated phase behavior of polyelectrolyte-protein systems.
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3.3.1.2 Effect of Salt on the Phase Diagram of HA-Lysozyme
In order to compare the effect of ionic strength of the DNA-lysozyme phase
diagram, a comparable range of HA-lysozyme samples at ImM NaCI, lOmM NaCI and
lOOmM NaCI were investigated. An increase in salt concentration also increased the
electrostatic screening in the polyelectrolyte-protein complexes. The total number of
homogenous complexes for which Rh could be determined with DLS decreased. At
lOOmM NaCI the scattering in all mixtures was minimal and the resultant correlation
information yielded no size information due to the poor scattering (Figure 3.15).
Previous studies in the literature have observed this loss of complex formation in HA-
lysozyme complexes in high salt mixtures. It had been observed that 20mM NaCI
produced the most favorable conditions for complex formation while at higher salt
concentrations, there was a loss of complexation.^"* The OmM NaCI phase diagram
included more soluble homogenous complexes than any of the other HA-lysozyme
phase diagrams at higher ionic strengths (only comparing up to 0.022g/L HA and up to
0.03 g/L lysozyme). From the DLS information at OmM NaCI the Rh for 10 different
samples was able to be determined but as the ionic strength increased it was observed
that fewer samples contained homogenous soluble aggregates. At lOOmM NaCI all the
samples showed low scattering and little correlation information could be gathered. This
indicated that with higher ionic strength, the formation of homogenous complexes was
electrostatically screened. It should be noted that this inhibition of homogenous
aggregate formation at high ionic strength was not observed in the DNA-lysozyme
complexes. These differences in complexation behavior between the two systems may
be attributed to the lower charge density on HA compared to DNA.
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In the HA-lysozyme complexes, the onset of phase separation occurred at
significantly higher polymer and protein concentrations compared to the DNA-
lysozyme mixtures. Upon visual inspection of various HA-lysozyme mixtures, some of
the mixtures appeared to exhibit different types of phase separation. Future studies of
complexation near the phase boundary and studies that would address the kinetics of
phase separation would possibly be able to determine the mechanisms of phase
separation that was occurring in the HA-lysozyme system. From this information it
could be concluded whether multiple mechanisms of phase separation were occurring in
the HA-lysozyme systems and compare these findings to the mechanism of phase
separation observed in the DNA-lysozyme complexes.
3.3.1.2 Dynamic Light Scattering of HA-Lysozyme Complexes
Determination of the average Rh of HA-lysozyme over all ionic strengths away
from the phase boundary showed an average spontaneous selection of size of
224± 10/im (Figure 3.10). If all calculated Rh values for the HA-lysozyme samples
were included, even the larger complexes in the metastable region, calculations resulted
in an average soluble complex size of 238 ±2\nm (Figure 3.9). In contrast to DNA-
lysozyme complexation, HA-lysozyme complexation occurred on either side of the
molar charge ratio boundary, even when the lysozyme molar charge ratio was in excess.
3.3.3 Comparison of the Two Polyelectrolyte-Protein Systems
3.3.3.1 Rh of the Soluble Complexes
Comparison of the Rh's of all soluble complexes over all salt concentrations in
the DNA and HA-lysozyme systems yielded an overlap in the average sizes of the
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complexes (Figures 3.9 and 3.10). DNA-lysozyme complexes had an average Rh of
286 ± 5 hvn while HA-lysozyme complexes had an average Rh of238 ± 2 Inm . For
both systems, these average sizes were weighted with larger complexes near the phase
boundary. Upon calculating the average Rh of the soluble complex away from phase
boundaries in DNA and HA systems, the average Rh in the two systems began to
converge (DNA-lysozyme complexes average Rh =235 ±\2nm and HA-lysozyme
complexes average Rh = 224 ± \ Qnm ), with salt showing little effect on the soluble
aggregate size (Figure 3.10). Amazingly, for both polyelectrolyte-protein systems a
spontaneous selection of soluble aggregate size away from the phase boundary was
approximately 230 nm, irrespective of polymer concentration, persistence length,
charge density or even the type of polyelectrolyte!
3.3.3.2 Fractal Dimension Analysis
The internal structure of an aggregate can be determined through static light
scattering analysis when the product of the scattering wave vector, q, and the radius of
the aggregate is greater than 1, qR>l. As a particle's size approaches the wavelength of
the probe being used, it becomes possible to investigate the intra-particle details of the
aggregate. For the experimental set-up used in these studies, in static light scattering,
qR>l occurs when a particle's Rh is greater than 100 nm. All of the aggregates that
were formed in this study were greater than 100 nm, and hence it became possible to
examine the intra-particle arrangement, which yields information about how the
polyelectrolyte and lysozyme pack themselves into a soluble complex. From the
scattering form factor, P(Q), information about the intra-particle structure and the
fractal dimension, df, can be determined upon application of equation 3.1:
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P(Q)~QA (3.1)
In equation 3. 1 . Q = qUh is a dimensionless quantity in which q is the scattering
wave vector (equation 2.2) and L,h is related to the radius of the aggregate. Analysis of
the aggregate's fractal dimension, df, gives insight into the arrangement of the
complexes" intra-particle structure.''^ A sample calculation of the fractal dimension is
shown in Figure 3.16. The results from the fractal dimension calculations of the soluble
complexes observed in this study were unexpected.
The DNA and the HA polyelectrolytes were chosen for this study because of
their similarity in molecular weights (2,600,000 g/mol compared to 2,400,000 g/mol)
and total number of charges per polymer (~ 8,000). Yet the polyelectrolytes differed
significantly in persistence length (lp~50 nm for DNA vs. Ip ~ 5-lOnm for HA). Due to
this difference in persistence lengths, it was hypothesized that comparison of the two
polyelectrolyte systems would give insight into the effect persistence length had on
polyelectrolyte-protein complexation.
Soluble complexes away from any phase boundary had an average Rh value of
roughly 230 nm in each system (Figure 3.10), which was discussed in Section 3.3.3.1.
This observation is quite outstanding and indicates that persistence length does not play
any role in the size selection of the aggregate. While each polymer system
demonstrated this spontaneous selection of size, it was hypothesized that while each
system may amazingly yield the same aggregate size, each polyelectrolyte-protein
complex must spatially arrange itself in a different manner due to the differences in
flexibility of the polymers. It was hypothesized that the less flexible polymer would
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yield a looser more branching type of aggregate structure because of its less flexible
nature.
Interestingly, calculations of the fractal dimension of DNA-lysozyme complexes
yielded a df of 3, which indicated that these aggregates had a more compact structure
similar to a sphere. The HA-lysozyme complexes exhibited fractal dimensions greater
than 3 which indicated looser packed soluble aggregate with a more branching like
structure (Figure 3.17).^^^"^^ These unexpected differences in the fractal dimensions are
quite exciting and indicate that persistence length plays no role in the intra-particle
arrangement of the polyelectrolyte-protein complexes.
The fractal dimensions observed in the DNA-lysozyme complexes were
insensitive to salt concentration, and at higher salt concentrations the df appeared to
converge toward three (Figure 3. 17).The HA-lysozyme complexes showed a wider
variation of fractal dimensions amongst the complexes, which can be observed through
the large error bars (Figure 3.17). This indicated that the HA-lysozyme complexes did
not have a consistent packing arrangement compared to the DNA-lysozyme aggregates.
Amazingly the DNA-lysozyme and HA-lysozyme complexes tended to have
approximately the same Rh, yet each aggregate's intra-particle arrangement was very
different and dependent upon the polyelectrolyte in the complex.
This observation of the spontaneous selection of size, yet different types of
intra-aggregate packing raises many more questions. What dictates the differences in
how each polyelectrolyte complex packs with the lysozyme? The resulting fractal
dimensions of the two systems indicated that persistence length was not playing a role
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in conipilexalion. Instead it was observed that DNA-lysozyme complexes were more
compact in their intra-particle aggregate arrangement than the HA-lysozyme aggregates.
For this study. Hyaluronic Acid and DNA were picked because each
polyelectrolyte had a similar number of charges per polymer chain and similar
molecular weights. It was proposed that the disparity observed between the fractal
dimensions were due to the differences in the charge density of each polyelectrolyte.
Since DNA has more charges per nm than HA, within the same distance DNA has more
effective opportunities to bind to a protein than HA. Hyaluronic acid has one charge
every nanometer whereas DNA has five charges per nanometer. Due to the higher
charge density DNA can be considered to have a more 'effective' opportunity to
electrostatically bind to the positively charged lysozyme. The ability of the DNA to
bind more effectively may contribute to a denser arrangement in the packing of in the
complexes.
The spontaneous selection of an Rh of 230 nm for the complexes, irrespective of
persistence length, charge density, ionic strength and intra-particle packing is still a bit
of a mystery. A study with HA-lysozyme at pH 2 showed aggregates that were much
smaller.^^ This finding leads to the question of: What role does the charges on the
protein play in the spontaneous selection of the complexes' size? This study suggests
future theoretical exploration of the spontaneous size selection of complexes and future
experimentation into how protein charge density or protein size and structure influences
this fascinating phenomenon in polyelectrolyte-protein complexes.
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3.4 Conclusions
• DNA-lysozyme biopolymers at low concentrations produced an interesting
phase diagram that contained four regions: phase separated homogenous soluble
aggregates, meta-stable solutions and clear inhomogeneous complexes.
• An increase in salt concentration in the DNA-lysozyme phase diagram increased
the number of samples that yielded clear homogeneous complexes in the salt
concentrations up to lOmM NaCl. At lOOmM NaCl salt concentration a reverse
of this electrostatic screening was observed and some sample concentrations that
contained soluble aggregates at lower salt concentrations showed precipitates as
the complexes appeared to be 'salted' out of the mixtures.
• The HA-lysozyme phase diagram was much different than the DNA-lysozyme
phase diagram. This system needed much higher polymer and protein
concentrations in order to induce phase separation.
• For HA-lysozyme complexes, increases in NaCl concentrations decreased the
number of soluble homogenous complexes that were observed, and at lOOmM
NaCl, all complexation was screened by the added salt.
• For both DNA-lysozyme and HA-lysozyme complexes a spontaneous selection
of size of 230 tmi was observed away from the phase boundaries. This size was
unaffected by persistence length, polymer, protein, or salt concentration.
• The fractal dimension of these aggregate structures was calculated in order to
determine how the polyelectrolyte and proteins compacted into a soluble
aggregate.
• DNA-lysozyme complexes produced a fractal dimension thai indicated the
complex was more compact than the HA-lysozyme complexes. This was an
outstanding discovery as it was hypothesized that since DNA is much stiffer
than HA, it would have had a looser soluble aggregate structure than the HA-
lysozyme aggregates.
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Figure 3.1: Phase Diagrams of DNA-Lysozyme Complexes Made in Solutions of (a)
OmM NaCl, lOmM Tris, pH 7 (b) ImM NaCl, lOmM Tris, pH 7 (c)
lOmM NaCl, lOmM Tris, pH 7 and (d) lOOmM NaCl, lOmM Tris,
pH 7. Samples above the black line are those which the moles of
negative charge on the DNA (8,000 negative charges per molecule) in
the solution are in excess, and samples below the black line indicate
complexes where the moles of positive charge contributed by lysozyme
(+8 per protein at pH 7) are in excess. Black circles denote the presence
of an insoluble precipitate, clear circles denote the presence of soluble
aggregates observed by DLS, the shaded circles denote observation
of metastable aggregates, and blue circles denote a region of clear
solutions with inhomogeneous scattering for which no size information
could be determined via DLS.
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Figure 3.2: Sample Correlation Functions from the Inhomogeneous Scattering
Regions
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Figure 3.3: DLS Correlation Functions for DNA-Lysozyme (0.009g/L:0.005 g/L)
Complex Between Angles of 35° and 55°
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Figure 3.4: A Calculation of the Diffusion Coefficient for a DNA-Lysozyme
Complex (0.009 g/L: 0.005 g/L) in OmM NaCI and lOmM Tris at pH
of 7. The graph was constructed from CONTIN analysis of the
correlation functions from which F (sec"') can be calculated for various
angles where q is the scattering wave vector defined as q =4;i— sm{—)
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Figure 3.5: Rh Values for DNA-Lysozyme Complexes in a OmM NaCI, lOmM Tris,
pH 7 Solutions. The black circles denote the presence of an insoluble
precipitate and the blue circles represent samples that had clear solutions
yet inhomogeneous scattering for which no size information could be
calculated from DLS experiments.
67
0.018 237 182 • • •
(g/L)
0.009
168 • •
0.005 222 263 •
1
•
Com
0.001
1
'
<
ZQ
().()003
0.005 0.01 0.015 0.02 0.03
Protein Conc.(g/L)
Figure 3.6: Rh Values for DNA-Lysozyme Complexes in ImM NaCl, lOmM Tris,
pH 7 Solutions. The black circles denote the presence of an insoluble
precipitate and the blue circles denote samples that contained clear
solutions yet had inhomogeneous scattering for which no size
information could be calculated from DLS experiments.
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Figure 3.7: Rh values for DNA-Iysozynie complexes in lOmM NaCl, lOmM Tris,
pH 7 solutions. The black circles denote the presence of an insoluble
precipitate; the grey circles denote the observation of an insoluble
precipitate that re-solublized upon agitation, yet no size information for
these samples could be determined and the blue circles denote samples
that had clear solutions with inhomogeneous scattering for which no size
information could be calculated from DLS experiments.
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Figure 3.8: Rh Values for DNA-Lysozyme Complexes in lOOmM NaCl, lOmM Tris,
pH 7 Solutions. The black circles denote the presence of an insoluble
precipitate; the grey circles denote the observation of an insoluble
precipitate that re-solublized upon agitation, yet no size information for
these samples could be determined and the blue circles denote
samples that had clear solutions yet inhomogeneous scattering for which
no size information could be calculated from DLS experiments.
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Figure 3.9: All Rh Values Calculated for DNA-Lysozyme and HA-Lysozyme
Complexes. The average size of the DNA-lysozyme complexes over all
salt concentrations was 286 ± 5 Inm and the average size of the HA-
lysozyme complexes was 238 ± 2 Imn . This average size of the
complexes was calculated from all the data available for the Rh values.
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Figure 3.10: Average Rh Values Calculated for Soluble Complexes Away From
Any Phase Boundaries for DNA-Lysozyme and HA-Lysozyme
Complexes. DNA-lysozyme complexes had an average Rh over all salt
concentrations of 235 ± 1 2utn and HA-lysozyme complexes had an
average Rh over all salt concentrations of 224 ±\Ofun .
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Figure 3.11: Phase Diagram for HA-Lysozyme Complexes in OmM NaCI, lOmM
Tris, pH 7. The clear circles denote samples that had homogenous
soluble aggregates; the black circles denote samples that showed an
insoluble precipitate; the shaded region denotes the observation of
samples that had insoluble precipitate yet also had a complex rich
supernatant; the blue circles represent clear solutions that had
inhomogeneous scattering for which no size information could be
calculated from DLS experiments and the red circles denote samples
where the observed precipitate had a refractive index similar to that of
glass and hence was difficult to observe and different than precipitates
observed denoted with a black circle. The black Une denotes where the
molar charge ration is 1:1; above the line the molar charge ratio of HA is
in excess, below the line the lysozyme molar chare ratio is in excess.
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Figure 3.12: Calculated Rh Values for HA-Lysozyme Complexes at OmM NaCI,
lOmM Tris, pH 7. The clear circles denote samples that had
homogenous soluble aggregates; the black circles denote samples that
showed an insoluble precipitate; the shaded region denotes the
observation of samples that had insoluble precipitate yet also had a
complex rich supernatant; the blue circles represent clear solutions that
had inhomogeneous scattering for which no size information could be
calculated from DLS experiments and the red circles denote samples
where the observed precipitate had a refractive index similar to that of
glass and hence was difficult to observe. The black line denotes where
the molar charge ration is 1:1; above the line the molar charge ratio of
HA is in excess, below the line the lysozyme molar chare ratio is in
excess.
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Figure 3.13: Resolved Rh Values for HA-Lysozyme Complexes in ImM NaCI,
lOmM Tris, pH 7 Solutions. The blue circles denote samples that were
clear with inhomogeneous scattering whereupon no size information
could be calculated from DLS experiments.
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Figure 3.14: Resolved Rh Values for HA-Lysozyme Complexes in lOmM NaCl,
lOmM Tris, pH 7 Solutions. The blue circles denote samples that were
clear with inhomogeneous scattering whereupon no size information
could be calculated from DLS experiments.
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Figure 3.15: A Sample Correlation Function for a lOOmM NaCI HA:Lysozyme
Complex. This is an example of the observed low scattering intensity at
low q value (30 degrees) and no further dynamics could be determined
due to the low scattering for samples in lOOmM NaCl for the
HA:lysozyme complexes.
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Figure 3.16: An Example of a Fitting for the Fractal Dimension, df, of a HA-
Lysozyme Complex (0.022g/L: 0.03g/L), in a Solution of OmM NaCl,
lOmM Tris, pH 7
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Figure 3.17: The Calculated Fractal Dimensions for Hyaluronic Acid-Lysozyme
and DNA-Lysozyme Soluble Complexes at Various Salt
Concentrations
79
chaptp:r 4
conclusions/future work
4.1 Complexation onto Curved Charged Surfaces
The focus of this work was to understand the adsorption of polyelectrolytes onto
curved charged surfaces. This research was divided into two sections. The first section
focused on how antimicrobials complex and kill bacteria; it was an investigation into
how a polyelectrolyte complexes with a curved surface much larger than its radius of
gyration. The second section focused on the complexation of polyelectrolytes with a
protein. In this comparison the focus was to understand how persistence length, ionic
strength and charge density of two different polyelectrolytes influenced the protein-
polymer isotherm that dictated the phase behavior of these two systems.
4.1.1 Antimicrobials: Complexation of Polymers and Biomimetic Vesicles
This collaborative work with Dr. Greg Gabriel and Professors Tew and
Coughlin investigated some of the aspects of the physical interactions between cationic
antimicrobial polymers and biomimetic vesicles in order to further understand how
antimicrobial polymers kill bacteria. From these investigations we discovered that
antimicrobial activity was dependent upon the fine tuning of the incorporation of
hydrophobic and cationic groups in antimicrobial polymers. Too much or too little
incorporation of hydrophobic side groups in the polymers yielded polymers that had no
antimicrobial activity. From the polymers synthesized, solution characterizations of
some of the polymers in low and high salt conditions were investigated as well as
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studies on how these polymers interacted with model biomimetic vesicles. These
biomimetic vesicle studies were meant to elucidate how antimicrobial polymers killed
bacteria.
Polyelectrolytes in low salt conditions can exhibit the presence of slow and fast
mode dynamics which can be characterized with dynamic light scattering (DLS). The
slow mode arises from to the aggregation of the polyelectrolytes while the fast mode is
considered to be the co-diffusion of the counter-ions on the polymer backbone and the
aggregate cluster. Polymers 1, 2, and 3 were characterized by DLS and SLS. From the
DLS analysis the presence of these two dynamics in low salt conditions were observed.
Typically with polyelectrolytes, as the salt concentration of a solution is increased the
slow mode dynamics disappear. In these polymers what was observed in higher salt
conditions was that as the electrostatic repulsion of the charges on the polymer was
screened, the hydrophobic interactions on the polymer chains began to have a greater
influence on the aggregation behavior of the polymers. Our results showed an increase
in the aggregation of the polymer chains at higher ionic strength which was observed
via DLS at higher salt conditions.
While characterization of these antimicrobials in solution gave us a better
understanding of the solution dynamics of the polymers, the focus of this collaboration
was to try to understand how these polymers induced antimicrobial activity in order to
efficiently design and tailor new antimicrobials. We pursued studies with these
antimicrobial polymer systems and biomimetic vesicles with the hopes of further
understanding the dynamics and the kinetics of the interactions with biomimetic
vesicles. These experiments were done with homopolymers and copolymer systems
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designed in the Tew group. In these studies we followed the change in Rh of the vesicles
upon addition of the antimicrobial polymers. It was found that the polymers that had
moderate to excellent antimicrobial activity, MIGx) > 200 |ig/mL, induced aggregation
of the vesicles. This aggregation did not correlate extensively with the observed MIC90
values, but it did indicate that the antimicrobial polymers induced aggregation to some
degree. From our results we concluded that for this specific polymer system it appears
that aggregation is a necessary, but not a sufficient precondition for antimicrobial
activity.
Potential future studies would include how aggregation is important to other
synthetic and natural antimicrobial molecules. This aggregation phenomenon was not
observed in another study with the host defense peptide gramicidin S and biomimetic
vesicles.
^"^'^^
It is of interest to explore whether or not this phenomenon is unique to
synthetic systems and why it appears to be an important indication of antimicrobial
activity for these polymers.
4.1.2 Polyelectrolyte-Protein Aggregates
The focus of the study of complexation of proteins with polyelectrolytes was to
understand how persistence length, ionic strength, and polymer and protein
concentration influenced the phase diagram and the protein adsorption isotherm. In our
studies we found that persistence length did not play an important role in
polyelectrolyte complexation. The two polyelectrolytes used in this research differed in
persistence length by an order of magnitude, yet it was observed in both polyelectrolyte
cases that the soluble aggregates of the polyelectrolyte-protein complexes that did not
reside near a phase boundary showed a spontaneous selection of aggregate size of about
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~235nm. This aggregate size was independent of the polymer flexibihty, and
independent of ionic strength in the solution. Further investigations into the intra-
particle packing of the complex revealed that the semi-flexible polymer, DNA,
produced complexes that showed tighter aggregate packing with the lysozyme proteins
than the more flexible polyelectrolyte, hyaluronic acid.
These findings were fascinating. Despite the differences in persistence lengths,
soluble aggregates that did not reside near a phase boundary had a similar size. This
leads to further questions of what factors influence the overall aggregate size in
polyelectrolyte-protein complex, and can this specific size be utilized to design different
types of complexes? Being able to dictate a specific the size of a nano-particle simply
by choosing the correct polyelectrolyte or protein for a complex would lead to a variety
of potential applications.
I
Some questions that arose from this study that need to be answered theoretically
include what parameters influence this spontaneous selection of size? How does the
molecular weight of the polymer influence the size of the aggregate? And how does the
surface charge density of the protein influence the aggregate size? Future experimental
studies on the influence of protein surface charge density could be easily explored by
varying the pH and observing how a change in the surface charge density influenced the
phase behavior and size of the aggregate. It would also be interesting to explore how the
size and total charge on the protein influenced the size of the soluble aggregates which
could be investigated with different proteins. Future work into the competitive nature of
protein binding and introducing different proteins to the aggregates would lend more
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understanding into the inllucncc of a niulti-coniponent system and il there is any effect
on how aggregates are formed.
Fully understanding the underlying principles that govern polyelectrolyte-
protein complexation have profound implications in being able to synthesize nano-
particles with specific sizes. Understanding what governs this great specificity will
allow further inspiration into how to design smart materials or even how to design a
specific sized nano-particle for protein drug delivery. The number of directions that
future work in the area of polyelectrolyte complexation can take is as varied and vast as
one's imagination.
As with any research, the number of questions that any body of work answers
only elicits as many if not more questions to answer. Further understanding into the
governing fundamentals that underlie the self assembly and complexation events that
guide nature's ability to create regular structures will allow us to utilize these unique
properties in building smarter materials and designing systems that can precisely self
assemble on the nano-scale.
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APPENDIX A
PROTOCOL FOR GROWTH AND PROPAGATION OF R408 PHAGE STOCK
PROTOCOL
Outline of the Preparation
Below this outline is a more detailed look at the preparation.
1 ) Advance preparations
a) Make at least 20 LB agar plates (with no Ampicillin)
b) Make at least lOOmL of Top agar
c) Need at least 50niL of LB liquid media
2) Streak bacteria on LB plates
3) Inoculate 2mL of LB
4) Dilute bacteria
5) Place LB top agar on hot plate '
6) Make serial dilutions of R408
7) Aliquot top agar
8) Bacteria preparation
9) Phage addition to bacteria
10) Label incubator plates
1 1 ) Remove top agar from water bath
12) Add bacteria/phage to top agar
13) Agar solidification
14) Incubate plates
15) Count plaques
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16) Pick plaques
1 7) Prepare phage stock solution
1 8) Determine the concentration of stock solution
Beginning notes:
Before doing any preparations, it is important to get trained to use the autoclave
that is below LGRT from whoever is in charge of the autoclave. Typically it is someone
in microbiology. Their phone number should be on the door to the autoclave. In Conte,
there are a few autoclaves in the Emerick and Lesser groups. Neither one is appropriate
for biological preps due to the lack of a liquid cycle. When being trained on the
autoclave, discuss with whoever is doing the training the proper techniques of how to
prepare containers with liquid (liquids should only take up 50% of a container, i.e.
250mL in a 500mL container). Make sure it is fully understood the types of cycles used
in the autoclaves and what they are used for (a dry cycle is to be used when no liquids
are being autoclaved, and a liquid cycle is for autoclaving liquids), how to
decontaminate and dispose of solid and liquid bacteria and bacteriophage waste.
Notes about the autoclave: Nothing, waste or things that are to be sterilized, can
be put into the autoclaved without secondary containment. There are a couple of
secondary containers in the lab that are autoclavable. They are made by Nalgene. It is
best to look in a Fisher catalog to see what they look like in order to identify these
containers. There are elbow length orange autoclave gloves in the lab. They must be
used when putting items into the autoclave and taking anything out, as the autoclave can
be extremely hot. In order to transport things to and from the autoclave there is a cart
that can be used to move things between the lab and the autoclave. Even though the
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items being autoclaved are in a secondary containers, when everything comes out of the
autoclave they will be hot and should not be transported back to the lab without a cart.
This is also for the safety of whoever is transporting items back to the lab. Liquids can
become superheated upon autoclaving and care should be exercised when removing
them from the autoclave. Jostling superheated liquids can cause them to boil and
potentially boil up and out of their containers. Beware of this during transportation.
The bacteriophage R408 used in this preparation is related to the bacteriophage
Ml 3. Professor Bermudez's group works with Ml 3 bacteriophage and may have
possible pointers on handling and growing of the cultures if there are further questions.
Training for this preparation was through Professor Hud's group at Georgia Tech.
When I was trained by this group they were phasing out this preparation so it is doubtful
that this prep is currently being utilized by his group. This protocol was a staple in
molecular biology in the early 1980s and background information can be found in the
Molecular Cloning books and books on bacteriophages in the library.
1 ) Advance Preparations
a) Make at least 20 LB agar plates (with no Ampicillin)
i) Dissolve lOg of agar and 6.25g LB in 250mL of water in a 500mL
screw cap glass container. The agar won't dissolve but try to make sure all the LB is
somewhat dissolved before placing in the autoclave (note: if a stir-bar was used to help
dissolve the LB, remove it before autoclaving otherwise it will interfere with the
pouring of the plates later). LOOSELY screw the cap on the container. It is best to place
some autoclave tape on the lid and attach it to the container such that if the cap were to
come off during autoclaving it will still be attached to the container. Attach one piece of
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tape from the top of the cap to the glass in a vertical manner, h is VITALLY important
NOT to fully screw the lid of the container down. Do not tape the lid completely down.
NEVER EVER HEAT A CLOSED CONTAINER IT WILL BREAK/EXPLODE.
Remember an autoclave is I25°C and high pressure. The purpose of having the cap
loosely screwed down is so that steam can escape while the container is in the
autoclave, otherwise the container will break.
ii) Pouring plates: In order to fully understand how to pour agar plates in
a proper sterile fashion, it is best to find someone to teach one how to do this. Below is
a synapses of how to pour plates in sterile fashion, but it is most effective to have a
teacher. Pouring sterile agar plates is a common practice in molecular biology, so it is
utilized throughout this disciphne. Professor Bermudez's group may pour their own
plates and Professor Craig Martin's group also pours their own agar plates. Either group
may have some tips.
It must be kept in mind that while these protocols are for growing bacteria,
everything must be kept sterile in order to isolate the type of bacteria desired and not
inadvertently grow every type of bacteria in the ecosphere found in the lab.
Notes on pouring LB plates: Take a 70% ethanol:water mixture and wipe down
the area that the plates will be poured. Take the empty plates that will be poured and
label the bottom of the plate indicating that the plates are free of antibiotics. (Typically
in molecular biology plates with antibiotics are denoted with a large black stripe down
the bottom of the plate.) Date and label the plates. Turn the plates right side up. It is best
to pour plates in an area of the lab where there won't be a lot of people walking around.
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After removing the LB-agar mixture out of the autoclave, let it cool until you
can touch/pour the LB-agar mixture with a gloved hand or your bare hand. This
typically takes about an hour from removing the LB/agar from the autoclave to being
able to handle the container and pour the plates. Remove the lid and tip the container at
a slight angle. Sterilize the top of the container with a Bunsen burner and begin to pour
the plates filling the containers Vi to % full. While pouring the plates, hold the breath
and pour as many plates as possible. When breathing is necessary, stop pouring and turn
the head away from the plates to breathe. Whenever the pouring is stopped to breathe,
re-sterilize the top of the bottle of the LB-agar media with the Bunsen burner before
pouring again. Put the covers on the plates so that 90% of the plate is covered, but a
little air can get out. When the plates have cooled and the agar is set (5-10 minutes),
cover the plates with their lids and invert them. Typically these plates would be left on
the bench overnight, closed and inverted, so that less condensation would build up upon
storage in the fridge. Most likely a few plates will be contaminated and bacterial growth
will be seen in the morning. Discard contaminated plates in the solid waste container
for bacteria. The next morning store the plates in the refrigerator upside down. It is also
convenient to put the plates back in the sleeve that they came in. When the plates are
inverted in the fridge, water will condense on the lid of the container (not where the
agar is).
Before using these plates to grow bacteria, is best to 'flick' the water off the lid
by holding the plates upside down so the agar is on the top and the lid is on the bottom
(agar is facing the floor) and quickly shake the water off the lid by holding the lid and
flicking it down (typically into a sink so water isn't all over the floor). The reason for
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getting rid of the excess water is that if it gets on the agar during any part of the
preparation the water is considered a contaminate and that plate is then considered
contaminated and cannot be used.
b) Make at least lOOmL of top agar (inckide a Teflon coated stir-bar when
autoclaving) in a 250mL Erlenmeyer flask
i) Take 0.7g agar and 2.5g of LB and mix in lOOmL of DI water in a
250mL Erlenmeyer tlask. Place a stir-bar in the LB-agar mixture, a piece of foil on the
top of the flask (using autoclave tape to keep it in place) and autoclave the flask.
c) Make at least 50mL of sterile LB liquid media.
To make LB media, take 25g LB in IL DI water. This ratio can be found
on the LB container. If making 1 L of LB, this needs to be done in a 2L container. Again
loosely place the cap on the container, and use tape to vertically hold the lid on. The lid
should be "tight" enough that when slightly pulled on it won't come off, but loose
enough that steam can get out and won't build up while autoclaving.
2) Streaking the Bacteria
Two days before the beginning of the preparation, streak CAG505 1 bacteria
onto a LB plate. This bacterium is in the -80°C freezer in the Tew lab B651, second
shelf from the top. Take a bucket with the LB plates, 70% Ethanol, pre-sterilized loops
(there are some individually packed ones in the lab and it is suggested that when
purchasing more only purchase the individually packaged sterile loops as multi-packs
will become contaminated after using one loop. None of these protocols necessitate
using multiple loops at one time.) Take a couple of loops up to the sixth floor for good
measure. On the second shelf there is a plastic container marked 'Muthugroup' that has
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the bacteria in eppendorf tubes. Take this container out of the -80°C freezer and remove
one tube of the CAG505 1 bacteria. Be careful when handhng the container and things
in the freezer as it is very cold. Utilize gloves of some variety or your skin will freeze to
things. Remove one tube of the CAG5051 bacteria and warm it in one's hand in a latex
glove until the top of the bacteria starts to melt, but do not completely thaw the bacteria.
Scrape the bacteria and streak the plates in a scribbly fashion going from a big scribble
to a little scribble from one side of the plate to the other. At the Bench (a book in our
lab) has a picture and a diagram of this procedure yet it calls for doing this in multiple
quadrants, but typically doing it once across the whole plate will work fine. Once the
plate is streaked, replace the lid and invert the plate so that the lid is on the bottom and
the agar is on the top. Place the inoculating loops back in their container making sure
not to get bacteria anywhere, or better yet, have a 15mL falcon tube with 70% ethanol
in it so that the loop can be decontaminated immediately. Put the bacteria back in the
freezer and wipe the area down with 70% ethanol.
Take the plate back to the lab and place it inverted in the incubator at 37°C
without shaking overnight. Take the contaminated loops and place them in the waste
container for autoclaving. It is best to streak the plate late in the day typically between
4-6pm and then see if there was enough growth by the next morning. Typically this
bacterium is quick to multiply due to the fact that there is no ampicillin resistance in the
bacteria. The fact that there is no antibiotic resistance calls for care of keeping all
working areas sterile otherwise more than just these bacteria will grow and if more than
the desired bacteria is grown on a plate, the plate is considered contaminated and can
not be used.
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All that is needed is a single isolated colony which is why it is best if the
bacteria does not gel overgrown otherwise the colonies will merge into one another
making it impossible to pick a single colony. Upon coming in the next morning, check
the colonies. If single colonies can be seen, take the plate out of the incubator. It is best
to leave the plate on the bench. The bacteria won't grow very rapidly once at room
temperature, but if there is concern that the colonies will impinge on one another before
the end of the day, place the plates in the refrigerator to slow their growth even more.
3) Inoculate 2mL of LB
The night before the experiment (4-6pm), inoculate 2mL of LB (without any
Ampicillin) with a single colony of CAG5051. Pick a single colony with an inoculating
loop from a plate of CAG505 1 that was streaked the previous night. Grow the 2mL of
LB plus bacteria overnight at 37°C with shaking ~250rpm. The 15mL Falcon round
bottom tubes work best for this. It is important to make sure not to completely cap the
top of the tube. These tubes can be capped loosely but don't push them all the way
down or the bacteria won't grow.
4) Dilute the Bacteria
First thing the next morning, dilute the bacteria 1:60 (250)al in 15mL of LB) in a
50mL conical tube. (A 50mL disposable tube with its cap loosely held on with tape will
work). Place it in the incubator at 37°C with ~250rpm of shaking for about an hour,
until it is slightly turbid. (OD530 = 0.4-0.6 ABS)
5) Place LB Top Agar on Hot Plate
After placing the diluted bacteria in the incubator, place the LB top agar on a
hot plate and set it to low heat with low stirring. It is best to keep an eye on this as
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important later when pounng the
top agar into the plates.
6) Dilutions of R408
R408 should be in the -20«C
freezer in the Muthu group lahs,
either tn the
.eezer that ,s In the
refngerator or in the freezer
that ts in the hallwa. Ma.e s,.
1:100
ethanol. Try to nunrnttze the
tinte the LB ntedia bottle and
R40S stoeK solut.on ,s open.
Add 990m of sterile LB to each
eppendorf tube that was pre-labeled
lO ", .0 ^
7) Aliquot the top agar
4n.L of .elted top agar to
each of the s.ertle Paleon ( 1
SntL. round bottom culture
tubes.
Place the tubes of top agar
in a 55°C water bath.
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8) Bacteria preparation
Remove the one hour bacteria cuhure from the incubator (from step 4) and
aliquot 200|li1 of bacterial cells to each of the six sterile eppendorf 1.5mL centrifuge
tubes and label them accordingly from 10 '^ to 10
9) Phage Addition to Bacteria
Add lOO^il of phage dilutions 10"^ to 10 to the corresponding labeled tube of
bacterial cells. Don't worry about the 10 " dilution as there are too many plaques to
count. After adding the phage dilution to the bacteria, gently mix the bacteria and phage
mixture by pipetting up and down. One tube of cells should not have any phage, which
can be used as a control. Incubate the bacteria with the phage dilution at room
temperature for 5 minutes.
10) Label Incubator Plates
At the two minute mark (from the previous step's 5 minute incubation), take the
plates from the incubator and label them 10'^, 10 10 and 10 and control. The 10 "
plate won't yield results that are useful so it is best to just skip that plate.
11) Top Agar from Water Bath
At the 1 minute mark remove the top agar tubes from the water bath. Generally
two at a time is the most reasonable number of tubes to work with at a given time.
12) Add Bacteria/Phage to Top Agar
At the 0 minute mark, add the cell/phage mixture (that was incubating on the
bench top) to the top agar tube. Vortex at setting 5, briefly (just enough to mix the top
agar and the bacteria/phage together) and pour in the center of the LB agar plates that
94
had been pre-warmed. Gently swirl the plate with the hd ON to distribute the top agar
evenly over the plate. Work quickly, but accurately and move on to the other dilutions.
13) Agar Solidification
Let the plate sit at room temperature to solidify before inverting the plates.
Close the lid completely while plates are solidifying.
14) Plate Incubation
After the top agar has solidified, invert and place in the incubator at 37°C
(without shaking) overnight before going home for the day.
15) Plaque Counting
First thing in the morning, remove the plates from the incubator and count the
plaques. Plaques will look like 'holes' in the lawn of bacteria. This is why the control
without the plaques are important, to see how the lawn of bacteria forms.
Plaque forming units (PFU)/mL = number of plaques on the highest plate
dilution X plate dilution X 10.
16) Plaque Picking
Sterilize the counter area with 70% Ethanol and put a sterile ImL pipette tip on
the sterile area. Sterilize a razor blade with ethanol and cut off the very narrow portion
of the tip. It is best to cut about 1cm or less of the tip off. Pick one plaque by pushing
the pipette tip into agar. When the tip is withdrawn from the agar the plaque should be
in the pipette tip. Use the pipetter to release the plaque/agar into 50mL of sterile LB
media that is in a sterile 250mL Erlenmeyer flask. Place flask in the incubator at 270
rpm, 37°C. and let it shake overnight. The phage needs lots of aeration which is why a
large flask is necessary.
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17) Preparing; Phaj»e Stock Solution
Take the 5()mL of LB/phuge from previous step and divide into two sterile
centrifuge tubes. Balance the tubes against one another. Pellet the mixture two times to
make sure all the bacteria cells are removed. Collect the supernatant and heat treat it for
30 minutes at 55°C. Let it slowly cool to room temperature and store at 4"C. According
to the book Molecular Cloning this stock solution of phage can be stored indefinitely
and still be active. I saw little decrease in phage plaque forming units after 2.5 years of
storage.
18) Determining the Concentration of Stock Solution
Repeat the whole phage titering process from the beginning of this protocol to
determine the concentration of the phage stock solution.
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APPENDIX B
LARGE SCALE SINGLE STRANDED DNA ISOLATION FROM R408
BACTERIOPHAGE
Take care to keep all areas sterile and bacteria free. Frequently wipe counters and
anything that containers come into contact with 70% ethanol.
1 ) Prepare the Starter Culture
Put 4]i\ of Ampicillin (50mg/mL) in 2mL of LB first thing in the morning
(around 8 or 9am). Pick (or scrape frozen) DH 125/pBluescript SK II (-)colony and
inoculate the LB. Shake at 220 rpm at 37 °C until 4 or 4:30 pm. Do these procedures
in a 15mL round bottom Falcon tube making sure that the cap isn't completely
sealing the tube. The mixture should be shghtly turbid by afternoon.
2) Prepare the Overnight Culture i
In the afternoon, (~4pm, when the bacteria starter culture is slightly turbid)
inoculate lOOmL of LB (best to have prepared lOOmL of LB in a 500mL or larger
Erlenmeyer flask and then autoclave it) with 200|al of Ampicillin (50mg/mL), ImL
of the starter culture from step 1 , 70^1 of phage stock (this is in the fridge and
according to the Molecular Biology Handbook this stock should be indefinitely
viable at 4°C. If there is concern about whether or not the phage is viable, utilize the
protocol for growth and propagation of R408 to see if the phage is still in the correct
infectivity range). Shake at 275rpm for at least 18 hours. (This prep has been
successfully scaled up to 200mL of LB, but any more than that makes the procedure
very tedious and is difficult to generate ssDNA that is of a reasonable purity.)
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3) Pellet the Bacteria
After 1 8 to 24 hours, spin down the culture in sterile centrifuge tubes at
6,0()0rpm, 4°C for 15 minutes. Make sure all tubes are balanced against one another
using a trip balance. Only load 30mL in the 50mL tubes otherwise there is risk of
the tubes leaking during centrifugation.
4) Decant the Supernatant
Decant the supernatant into 50mL conical tubes. If the pellet is loose re-spin the
mixture.
5) Precipitate the Phage
Add 6.25inL of the phage precipitation solution per 25mL of the supernatant.
Do this in 50mL Falcon tubes.
Phage Precipitate Solution: 40% (w/v) PEG 8,000 dissolved in 2.5M
NaCl.
Cap and invert the tubes to mix. Store the tubes at 4°C overnight or for two
hours for the phage to precipitate. Generally the best results came from letting the
phage precipitate overnight.
6) Isolate the Phage Precipitate
Take phage precipitation/supernatant mixture and pipette them into centrifuge
tubes with 25mL pipetter and balance them against one another. Spin samples at
10,000 rpm.
7) Decant the Supernatant
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Decant the supernatant into another container (Add bleach with at least 50%
bleach mixture, let sit for a few hours before disposing). DO NOT USE BLEACH
IF USING AMMONIUM ACETATE IN THE PHAGE PRECIPITATION
SOLUTION!!!
8) Pool the Pellets
Add ImL of IX TE pH 8.00 to the pellet and pool the pellets in an eppendorf
tube. For best results either don't pool all the pellets together or pool only 2 or 3
together. The more pellets that are pooled together the more difficult it can be to get
clean extractions and the greater risk that multiple extraction steps will be need.
With every extraction step there is risk of lowering the yield of DNA. Do these steps
in the hood.
9) Re-precipitate the Phage
An added step that sometimes was used (although not sure if it made the prep
any better) was to spin the tubes at 14,000 rpm for 15 minutes, decant the
supernatant and re-suspend in 1.5mL of Ix TE, pH 8.00 before doing the extraction
steps.
10) Aliquot the Aqueous Layer
Place 750)il of the TE mixture in each eppendorf tube.
1 1 ) Chloroform Extraction
Add 750^il of Chloroformiisoamyl alcohol to each tube(24:l).
12) Vortex Mixture
Vortex for 1 full minute.
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13) Spin the Samples
Spin at 1 2,000 ipm, room temperature for 5 minutes.
14) Remove the Aqueous Phase
Transfer the upper aqueous phase leaving the protein at the interface behind.
1 5) Repeat steps 11-14
1 6) Phenol Extraction
Extract the upper aqueous phase with equal volume of TE saturated
phenol:chloroform:isoamly alcohol (25:24:1) USE CLEAR TUBES!
17) Vortex Mixture
Vortex one full minute.
18) Remove the Aqueous Phase
Transfer the upper aqueous layer into an eppendorf tube and spin 14,000 rpm, 5
minutes at RT.
19) Repeat steps 17-19
20) Protein at the Interface
If there is still protein seen at the interface, it is suggested to repeat steps 17-19
again.
2 1 ) DNA Precipitation
In an eppendorf tube, take 300|al of the ssDNA in the aqueous layers (it may be
necessary to combine aqueous layers), 150|al of sodium acetate or ammonium
acetate, 900|al of 95% ICE COLD ethanol or 100% ethanol. Leave overnight at
-20°C or 10 to 15 minutes in -80°C.
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22) Pellet the DNA
Pellet the DNA in a cold centrifuge (this is located on the 3'^'' floor across from
the Analytical Ultracentrifuges) at 14,000 rpm for 15 to 30 minutes.
23) Remove Supernatant
Pipette off the supernatant.
24) DNA Wash
Wash with 70% ethanol and spin at 14,000 rpm for 15 to 30 minutes.
25) Repeat
Repeat previous step.
26) Remove Ethanol
Pipette off the ethanol, mark where on the tube the DNA pellet is located
(because once it is dry the pellet will be difficult to see) and flip upside down and let
dry overnight.
27) Re-hydrate
Typically a IX TE can be used to re-hydrate the DNA.
28) Check Concentration
Check the concentration and purity with UV-Vis. The concentration for ssDNA
is A26o=l is 33ug/mL. The X = 260nm/280nm ratio will tell the DNAiprotein ratio
and the purity of the mixture. Ratios greater than 1 .7 are typically considered clean.
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APPENDIX C
GROWTH AND PROPAGATION OF DOUBLE STRANDED DNA
This is a procedure that is a narration of the maxi-prep kit by qBiogene. Refer to the
directions with the kit. All reagents come with the kit.
1 ) Starter Culture
Scrape frozen DNA pBluescrpit SK II(-) with a sterile loop and inoculate 2mL
of LB with 4\xl Ampicillin (50mg/mL) first thing in the morning (8-9am). Use a
15mL Falcon tube. Put in the shaking incubator at 220rpm, 37°C until 4 or 4:30
pm.
2) Overnight Culture
Have 200mL of LB sterilized in a 500mL to IL Erlenmeyer flask (make the LB
in the flask and then sterilize it with a piece of foil covering over the top while
autoclaving). Using sterile technique, add 400fil of the starter culture and 400fil of
Ampicillin (50mg/mL). Shake the bacteria overnight at 250 rpm, 37°C.
DNA Isolation
3) Equilibrium Buffer to Column
In the morning (~9 am if the overnight culture was started -4:30 pm), add
equilibrium buffer (30mL) to the column and place a beaker under the column.
4) Centrifuge Overnight Culture
Split the overnight culture into centrifuge tubes and balance. Currently the
centrifuge on the 6* floor only will take 50mL tubes. We have some of those.
Make sure these tubes have been autoclaved before putting the bacteria into the
tubes. Measure out the 30mL with the disposable 30mL pipettes and the automatic
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pipetter. It is much easier than the bulb pipetters. Only put 30mL in each tube as
the tubes are only designed for that amount of liquid and putting more liquid in the
tubes may cause them to leak during centrifugation. Balance them against each
other with the trip balance. If they are not quite the same weight, rather than try to
redistribute the bacteria, use some DI water to get the tubes to balance one
another. Trying to redistribute the bacteria will only add to the possibility that the
bench and the samples will become contaminated. Use 70% ethanol to wipe down
the exterior of the tubes to make sure they are decontaminated and always wipe
down any area that has been utilized for preparation or transfer of bacteria. Once
the tubes are balanced against one another for the centrifuge, centrifuge at 6,000 x
g at room temperature or 4°C to pellet for 15 minutes.
5) Decant the Supernatant
Remove all the liquid from the pellet. Pour the supernatant into a separate
container and add 50% bleach to the container to decontaminate the supernatant.
Try to remove as much liquid from the pellet as possible. If it is needed, use an
automatic pipetter being careful not to disturb the pellet.
6) Re-suspend the Pellets
Re-suspend ALL the pellets with only lOmL of cell re-suspension buffer. Add
lOmL of the buffer to the first tube and vortex the tube until the pellet has been re-
suspended, then take the re-suspended pellet and add it to the next tube. This is
assuming only 200mL of initial bacteria was spun down. If using more in the over
night prep, adjust accordingly. Add lysis buffer to the re-suspended pellets
( 1 OmL) and incubate for 5 minutes at RT.
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7) Neutralize the Mixture
Add neutralization buffer ( lOniL) and mix to homogeneous. DO NOT
VORTEX.
8) Centrifuge
Balance the tubes and centrifuge at 12,000 x g for 10 minutes. Generally this
was not enough time to get the layers to separate and a pellet to form. Typically 15
to 30 minutes would make the separation easier. Typically a nice pellet wouldn't
completely form and part of the pellet would be at the bottom, but there would
also be some of the snotty homogenate at the top too. Using a pipette, pull off the
cleared lysate in the middle of the tube and try not to get any of the homogenate
that should be in the pellet. Put the cleared lysate in a 50mL falcon tube and let it
warm to room temperature before placing on the column.
9) Put DNA on Column
Once the cleared lysate is warmed to room temperature, put it on the column.
Discard the flow through.
10) Wash the DNA
Add column wash buffer (60mL) and discard the flow through.
11) Elute the DNA
Put a clean, autoclaved centrifuge tube underneath the column and add the
elution buffer (15mL).
1 2 ) Precipitate the DNA
Add sodium acetate, NaAc (7.5mL), and 95% ethanol (30mL) to the eluted
DNA from step 13 and place the tube in the freezer. This will help the DNA to
104
precipitate. This can be put in the -20°C freezer overnight or in the -80°C for 10
minutes.
13) Centrifuge
Balance the tube with another tube filled with water and centrifuge at 12,000 x g
for 30 minutes at 4°C. If there is no pellet, put the mixture back in the freezer.
Generally if the mixture has been left overnight in the freezer it is possible to see
the DNA when the mixture is gently swirled. Remixing the mixture so that it is
homogeneous will negatively impact the ability to recover a pellet. The purpose of
gently swirling the mixture is to observe that the mixture has started to separate,
but remixing it will hinder efforts to recover the DNA. Centrifuge the mixture at
1 2,000 x g for 30 minutes at 4°C.
14) Wash the Pellet
If a pellet is observed, then pour off the supernatant. If no pellet can be
observed, then take the mixture and place it in the freezer overnight again. At
times the pellet can be difficult to see if the yield is low. If more than a 200mL
overnight prep was done, the pellet should be pretty easy to see. Once the pellet is
observed, pour off the supernatant and add 70% ethanol (5mL) to the pellet.
Balance the tube with a tube of water and centrifuge the two tubes at 12,000 x g
for 5 minutes at 4 °C.
15) Dry the Pellet
Remove the supernatant and mark on the outside of the tube where the pellet is
before inverting the tube to let it dry.
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16) Re-suspend the Pellet
Once the pellet is dry (this won't take too long, couple of hours to overnight),
re-suspend in the desired buffer/salt solution.
17) DNA Integrity
Check DNA by gel electrophoresis.
18) DNA Concentration
Check concentration of DNA via UV-Vis. A'k = 260nm/280nm ratio of 1.7 or
greater will tell that the DNA is clean. Typically with a DNA maxiprep kit, in
order to do a UV-Vis it will be necessary to dilute the DNA to about 50X
otherwise the UV-Vis will be over loaded. Try to get an Abs reading in the X =
280nm region ideally around 0.5-0.8 Abs, but can be up to 1 Abs. If the reading is
less than Abs = 0.5 ideally prepare a more concentrated mixture accordingly. Any
greater than 1 Abs should be diluted down as the reading won't be as accurate. 1
Abs = 50)^g/mL of dsDNA. Once a A, = 260nm reading is in the 0.5-1Abs range
look at the >l = 280nm reading and this will give the DNA to protein ratio which
gives an indication of the purity of the DNA. If the prep yields a poor ratio, the
best way to recover the DNA is a phenol:chloroform extraction, but typically this
is only suggested if there seems to be a high yield of DNA. Do one
phenolxhloroform extraction according to the ssDNA protocol. This is only
suggested if there is potential for a large yield as quite a lot of DNA is lost in this
procedure.
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APPENDIX D
PRECIPITATING DNA
This protocol is for DNA recovery from a solution. This is best done in eppendorf tubes
with volumes 1.5mL or less except if the large liquid volume of DNA/liquid has
potentially a huge amount of DNA in it.
1) Add Sodium Acetate
Add 50% of the volume of DNA mixture of 3M of sodium acetate
(NaAc) to the DNA mixture that is to be precipitated.
2) Add Ethanol
ICE COLD 100% ethanol. This is typically 2-3x the volume of the
volume of the DNA mixture being used (Make sure the 100% ethanol has been
cooled in the freezer) When adding ice cold ethanol, slowly pipette up the cold
ethanol. If this is done quickly 'bumping' of the ethanol up into the pipetter is
possible which will contaminate the DNA. Slowly pipette the cold ethanol.
'Drop' the cold ethanol from above the mixture of DNA and sodium acetate
solution. Don't place pipette tip in mixture when adding the ethanol. By placing
the tip in contact with the liquid mixture, there is a risk that the DNA will attach
to the pipette tip.
3) Mix
Invert the mixture a few times.
4) Precipitate
Put precipitate mixture in the -80°C freezer for a half an hour or in -20°C
for a few hours to overnight.
5) Centrifuge
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Spin in a cold centrifuge (there is one in the Hayward lab on the 3*^ floor
across from the Analytical Ultracenlrifuge) for 30 minutes.
6) Remove Supernatant
Once a pellet is formed, slowly pour off the supernatant.
7) Wash Pellet
Add 200|Lil of 70% ethanol and spin the tube for 15 minutes. Repeat 2 or
3 times. This step will get rid of the high salt of the sodium acetate. Take care
not to pipette up the DNA. It is good practice to mark on the tube the location of
the DNA pellet as the pellet is off-white when it is wet but will turn clear after it
is dried and will be difficult to see after it has dried.
8) Dry Pellet
Invert the eppendorf tube and let it dry.
9) Re-hydrate DNA
Add the desired buffer mixture and mix the solution. Check the
concentration and purity of the DNA with UV-VIS. dsDNA Abs26o= 1, this
equals 50)Lig/mL. Absorbance at ?^ = 280nm is protein absorption. The
?L=260nm:280nm ratio is the DNA:protein ratio and determines the purity of the
DNA. Ratios greater than 1.7 are considered relatively 'clean' DNA.
Example Recipe
900|^1 Ethanol
300^1 DNA
150|al Sodium Acetate (NaAc)
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APPENDIX E
AGAROSE GEL PREPARATION
Microwave instructions for agarose gel concentration < 2% weight/volume (from The
Sourcebook
, p. 19) .
1) Set Up Flask
Take an Erlenmeyer flask that is 2-4 times the volume of the end solution and a
stir bar.
2) Add Buffer
Add room temperature IX or 0.5X of the desired buffer (The amount of buffer
and agarose is dependent upon the size of the gel being cast. For the size of gel that
was typically utilized with the electrophoresis unit in the lab, a 1.2% gel was 0.84g
of agarose and 70mL of 0.5X TBE, run at 5 volts/cm or 1 lOvolts for 1-1.5 hours )
Look at The Sourcebook to decide which buffer. Doing a typical DNA gel, 0.5X
TBE worked fine.
3 ) Hydrate Agarose
While the buffer is rapidly stirring add the agarose by sprinkling it in. Let stir
rapidly for a few minutes to hydrate the agarose
4) Remove Stir Bar
Remove the stir bar if it is not Teflon coated.
5) Cover Flask
Cover flask with plastic wrap and poke holes in it.
6) Weight Flask
Weigh the flask before heating.
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7 ) Heat Solution
Heat the solution on HIGH in the microwave until bubbles form.
8) Re-suspend Agarose
Remove the flask from the microwave (Make sure to use heat gloves, as the
flask will be very hot) and GENTLY swirl to re-suspend any gel pieces or powder.
9) Boil Solution
Heat the beaker on HIGH until the solution comes to a boil.
1 0) Dissolve Agarose
Hold at boiling for one minute or until all the particles are dissolved.
1 1 ) Remove Flask
Remove flask from microwave (use hot gloves as the flask is VERY hot).
12) Mix Agarose
Swirl GENTLY to mix agarose thoroughly.
13) Obtain Initial Concentration
After dissolution, add sufficient hot distilled water or buffer to obtain initial
weight.
14) Mix Thoroughly
15) Cast Solution
Cool solution to 60 °C before casting. (If adding Ethidium Bromide to the gel it
is generally added at this stage. Typically 0.5-l|il of 10 mg/mL EtBr is added to the
gel for the size run in the lab. Handle cautiously!!! EtBr is a mutagen. Make sure
tips that have come in contact with the EtBr and the gel that has been run are placed
in the solid hazardous waste bin. Molecular Cloning has more information on
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ethidium bromide handling and disposal. When in doubt ask EH&S.) Once the
solution is cast, place the combs in the gel while it is setting up.
16) Solidify Agarose
After the agarose is cast, let it solidify for at least an hour.
17) Add Gel Running Buffer
Pour gel running buffer so that the buffer is l-2mm above the gel. The buffer
used to make the gel is typically the same as what is used for the gel running buffer.
18) Mix DNA with Gel Loading Buffer
Mix the DNA with an appropriate gel loading buffer. These are typically blue
dyes. This helps with the visualization of the DNA in the gel and the dye will
migrate during electrophoresis to see that it is operational. Load the DNA into the
gePs wells.
19) Determine Voltage to Run Gel
Check with The Sourcebook on voltage per centimeter of running the DNA. The
amount of voltage per centimeter depends upon the molecular weight of the DNA
being run and also how far the DNA needs to be run onto the gel. Molecular
Cloning Books also has useful information on running DNA gels. Professor
Hoagland's group also runs agarose gels with DNA on occasion and they can be a
source of information.
20) Staining Gel
If the gel was preloaded with ethidium bromide, it is typically not necessary to
stain the gel after the gel was run with an ethidium bromide/buffer solution. If the
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ethidium bromide was not included in the gel, look at The Sourcebook on staining
procedures.
2 1 ) Image Gel
The UV-transilluminator in Conte is in Professor Hoagland's lab. That
transilluminator is mainly compatible with ethidium bromide, both in how it excites
the molecules and in the camera capture. If a different stain is being utilized there
are other transilluminator resources in LGRT.
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